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One of the fundamental problems in eukaryotic gene
expression is to understand the effects of multiple induction.
Here, the effect of single and combined treatment of rats with
3-MC and BHA on p-nitropheno 1 UDPGT gene expression was
investigated. Antibody against the purified 3-MC form of
UDPGT (Mp 57K) cross-reacted and differentially absorbed out
activity from all the other treatments. Monospecific anti¬
sera preferentially recognized the 3-MC and BHA + 3-MC forms
of the enzyme. Tryptic digest analysis showed conserved and
variable amino acid residues between BHA and 3-MC UDPGT.
Moreover, additive accumulation of polysomes, total RNA and
specific poly(A'^) RNA was demonstrated. Lambda gtll rat liver
cDNA library was immunoscreened. Based on these data, we
contend that BHA and 3-MC induce different forms of UDPGT and
as such modulate gene expression by activating two or more
separate genes.
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UDP-glucuronyltransferase (UDPGT, EC 2.4.1.17) is an
integral component of the microsomal membrane (Hochman et
al., 1981; Mackenzie, 1987). This enzyme exists as a
heterogenous molecule (Dutton, 1980) consisting of a family
of isozymes that are structurally related, but differ in
their substrate specificities and responses to different
inducers. Three forms of UDPGT having overlapping sub¬
strate specificities and different degrees of regulation by
compounds such as phenobarbital and 3-methylcholanthrene
(3-MC) have been identified in the rat (Bock et al., 1979),
rabbit (Tukey and Tephly, 1981) and guinea pig (Hochman and
Zakim, 1983). As a group of enzymes, UDPGTs are difficult
to solublize, and in general are quite unstable after
partial purification. Therefore, until now, much of the
data on substrate specificity has been obtained using crude
homogenates. We know that UDPGT catalyzes the glucuron-
idation of a wide variety of endogenous and xenobiotic
compounds (Boutin et al., 1984; 1985). For the present,
our knowledge of the number of multiple forms and their
substrate specificity is inadequate because of the diffi¬
culties involved in purification, isolation and resolution
of the different isoforms.
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Probably, multiple forms of the transferase have
evolved specifically to metabolize endogenous compounds in
various tissues, and each form of transferase so far isolated
might be specifically involved in glucuronidating a single
endogenous substrate.
General Overview of Xenobiotic Metabolism
Generally, xenobiotics are compounds that are exogenous
to the normal metabolism of an organism and may include
endogenously generated metabolic intermediates that the
organism cannot utilize. A molecular understanding of
xenobiotics metabolism and their interaction with living
organisms is essential for the rational development of new
therapies, for the determination of toxic hazards, and for
the development of new biocides for agriculture and medi¬
cine.
Interaction with xenobiotics involves several steps:
(1) Exposure: The way in which an organism becomes
part of an environment containing the foreign
compound.
(2) Uptake: Involves the biochemistry of cell mem¬
branes in the portals of entry and the structure-
function relationships in xenobiotic absorption.
(3) Distribution: Involves the mechanism of trans¬
port throughout the body and the distribution
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between tissues of the xenobiotic or its meta¬
bolites.
(4) Metabolism: Takes place at the portal of entry or
in such organs as the liver and extrahepatic
tissues, and involves the study of the enzymes
that detoxify and/or activate xenobiotics (Hodgson
and Guthrie, 1980).
The principal portals of entry for xenobiotics are
the skin, the gastrointestinal tract, and the lungs (Nelson,
1961). In most cases, the foreign compound must pass
through a number of biological membranes before it can be
distributed throughout the body and uptake depends on the
membrane as well as the physical properties of the xenogen.
The 1ipophi1icity of the cell membrane is the most important
factor in the uptake of exogenous molecules (Castuma and
Brenner, 1986) and active transport or pinocytosis is not
as common as diffusion in the uptake of xenogens across
lipid membranes. Furthermore, the majority of xenobiotics
that enter the body are lipophilic (Eisenberg and McLaughlin,
1976).
The metabolism of xenobiotics, which is carried out by a
wide range of relatively nonspecific enzymes, serves to
increase their water solubility and make possible their
elimination from the body (Conney, 1967). The process of
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biotransformation consists of two phases. In Phase I, a
reactive polar group is introduced into the molecule, render¬
ing it a suitable substrate for Phase II reaction (Magdalou
et al., 1982). The Phase I reactions which activate the
xenobiotic include the wel1-documented cytochrome P-450-
dependent mixed function oxidations as well as reductions
and hydroxylations. Since the electrons required in the
reduction of cytochrome P-450 are derived from NADPH, the
overall reaction can be written as follows (where RH is the
substrate):
RH + O2











+ H 2 0
P-450
On the other hand, Phase II reactions include all the conju¬
gation reactions in which a polar group on the xenogen is
combined with an endogenous compound such as glucuronic acid,
glutathione, sulfate, glycine and glutamate to form a highly
water-soluble conjugate that can be eliminated from the
body. Although the liver is the most studied organ with
regard to xenobiotic metabolism, several other organs are
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known to be active in this respect; however, neither the
specific activity nor the range of substrates metabolized is
as large as in the liver. An organ such as the kidney, may
also be an important site for xenobiotic metabolism (Bock
et al., 1984). The distribution of xenobiotic metabolizing
enzymes among organs is still a subject for more investi¬
gation.
Because foreign compounds are both activated and in¬
activated metabolically, physiological factors affecting
metabolic rates can have dramatic effects on the induction
of gene expression by the xenogens. These factors include
sex, age, pregnancy and diet as well as route of adminis¬
tration (Conney et al., 1977; Wang et al., 1986).
Xenogens can be substrates, inhibitors, or inducers
of the enzymes that metabolize them and, not infrequently,
serve in more than one of these roles. Since the enzymes
in question have multiple substrates, numerous interactions
between foreign compounds are possible. These may be
synergistic or antagonistic and may have a profound effect
on the metabolism of the xenogen (Sanvordeker and Lambert,
1974). Depending upon the compounds and the enzymes invol¬
ved in a particular interaction, the effect can be an
increase or decrease in gene expression.
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The cell type that has been studied most extensively
in association with xenobiotic metabolism is the hepatocyte,
the cell that forms the bulk of the liver. These cells are
highly active metabolical 1y, both in normal intermediary
metabolism and in reactions involving xenobiotics (Chen and
Andrade, 1976).
The action of xenobiotics has also been demonstrated in
the nucleus. The chromosomes which contain the DNA responsi¬
ble for the code for most of the proteins synthesized in the
cell is the site for the primary reaction in carcinogenesis,
since some carcinogens covalently bind to DNA (Nebert and
Felton, 1976). Depending upon the xenogen, the organ, and
the cell type involved, similar reactions are involved in
mutagenesis and other reproductive effects as well as in
teratogenesis (Hucker, 1970). The nuclear envelope has
recently been shown to have an active aryl hydrocarbon
hydrolase (a component of the cytochrome P-450 system).
Both the rough and smooth endoplasmic reticulum are active
in the oxidation of xenobiotics; usually the smooth ER has
the highest specific activity (Bochard et al., 1975).
Following phase I enzyme activation of a xenobiotic in
the body, the metabolite ultimately arrives at a site of
action such as the nucleic acid and proteins, or is conjugat¬
ed with a hydrophilic compound by the deactivating enzymes.
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Although almost any organ can be affected by the xenogen,
some are more easily affected than others by particular
classes of xenogens, and some have been studied in greater
detail than others. Some of these responses seem to be
receptor mediated. In all cases, however, xenogen-receptor
interactions are of importance, and actively investigated.
Some xenogens tend to affect either oxidative metabolism,
the synapses of the nervous system, or the neuromuscular
junction (Smith, 1978). The most common modes of action of
xenogens involve interaction with nucleic acids, causing
carcinogenesis or reproductive effects (Leonard and Jacob,
1977), Many metabolic pathways are affected by xenogens.
These include glycolysis, the tricarboxylic acid cycle, the
pentose cycle, the electron transport system and oxidative
phosphorylation, nucleic acid synthesis, protein synthesis,
as well as specialized systems as photosynthesis in plants
(Yu, 1977). For instance, some of the xenobiotics can act
as uncouplers of oxidative phosphorylation such as dinitro-
phenols (Dills and Klaasen, 1986), and others can alter the
expression of the enzymes involved in intermediate meta¬
bolism such as acetaminophen that increases blood alanine
amino-transferase levels (Hjelle et al., 1986). Either the
unmetabolized xenogen or its metabolic products are ulti¬
mately excreted, the latter usually as conjugated products
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resulting from Phase II reactions. The two primary routes
of excretion include the urinary system and the bilary
system (Hodgson and Guthrie, 1980). Minor routes include
the lungs, sweat glands, sebaceous glands, hair, feathers
and nails (Hodgson and Guthrie, 1980), Sex-related routes
such as milk, eggs and fetus also contribute to xenobiotic
excretion (Kitchin and Ebron, 1983).
G1ucuronidation as a Detoxification Mechanism
G1ucuronidation, catalyzed by UDP-glucuronyltrans¬
ferase, represents one of the major biotransformation pro¬
cesses involved in the elimination of endogenous and xeno¬
biotic compounds from the body (Dutton, 1980). This process
involves the conjugation of compounds to UDP-glucuronic
acid, which renders them more water-soluble and thus more
easily excreted from the body. Substrates for glucuroni-
dation include compounds possessing a hydroxyl, an amino,
or a carboxylic acid group. Most of the substrates of
UDPGT are the metabolites formed after a compound has been
biotransformed by the Phase I enzymes (e.g. cytochrome
P-450), specific hydrolases, N-oxidases and epoxidases.
Both Phase I and II biotransformations take place mainly in
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the liver, though these enzymes have been found in extra-
hepatic tissues such as lung, spleen, kidney and small
intestine (Wishart, 1978; Schwenk and Locher, 1985),
The conjugation of numerous chemicals of diverse struc¬
ture is believed to be accomplished through the selective
induction of distinct forms of UDPGT (Bock et al . , 1982).
The three most common types of glucuronic acid conju¬
gations involve the reaction of the co-substrate uridine
diphosphate glucuronic acid (UDPGA) with an aglycone (Fig.
1).
0-Glucuronides: This type of glucuronidation occurs
with primary, secondary, and tertiary alcohols and
phenols.
N-Glucuronides: Here the glucuronyl moiety attaches
to the nitrogen of the aglycone with one of the fol¬
lowing functional groups: aromatic amino group,
sulfonamide group, carbamyl group, or heterocyclic
nitrogen group.
S-G1ucuronides: A number of thiol compounds are con¬
jugated with glucuronic acid, S-glucuronidation is
not very common, but is similar to N-glucuronidation
in that the glucuronides formed are acid labile.
Fig. 1 Illustration of the glucuronidation reactions:
Glycoside bond formation may occur with 0, N, S
and C atoms, forming the glucuronide.
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It has been shown through substrate specificity stud¬
ies that some xenobiotics, such as 3-methy1cholanthrene and
phenobarbital , and some endogenous compounds, such as glu-
cucorti coi ds, induce distinct forms of this enzyme (Bock
et al., 1984), Additional support for the heterogeneity of
UDPGT is the reported separation of distinct enzyme forms
from rat and mouse liver via chromatography or chromatofo-
cusing procedures (Tukey and Tephly, 1981).
The phenolic antioxidant butylated hydroxyanisole has
also been shown to stimulate UDPGT activity in mammalian
tissues (Moldeus et al., 1 982) and has been reported to
induce specific molecular forms of this enzyme (Sato et al,,
1984). These observations are important because of the
prevalence of this antioxidant in the human environment
(mainly as a food and drug additive) and because some in¬
vestigations have shown that it inhibits some of the harm¬
ful effects of other xenobiotics such as their toxicity,
carcinogenicity and mutagenicity (Salocks et al., 1981;
Miranda et al., 1981),
Because of the biological significance of UDPGT, it
is important to determine the molecular basis of its multi-
plicity and the interrelationship(s ) among the different
forms. This will in turn assist in the elucidation of the
mechanisms involved in the regulation of UDPGT gene(s).
CHAPTER II
REVIEW OF LITERATURE
Physical and Functional Characteristics of P-nitrophenol
UDPGr.
SDS gel electrophoresis has revealed subunits from
50,000 to 57,000 daltons for p-nitrophenol UDP-glucuron-
syltransferase (Tukey and Tephly, 1981; Peters and Jansen,
1988). This enzyme has a half-life of 18 to 20 days when
stored at 0°C, and the addition of small phospholipid
vesicles considerably improves the stability of the trans¬
ferase. Storage by freezing at ■20°C in 20% (w/v) glycerol
results in a complete loss of activity. The enzyme is also
thermolabile at 37°C for longer than 15 min. Extensive
vacuum dialysis results in a loss of up to 40% of enzyme
activity (Tukey et al., 1981). The purified transferase
appears to exhibit absolute specificity toward UDP-glucu-
ronic acid as the sugar nucleotide.
Native polyacrylamide gel electrophoresis has revealed
a polypeptide of about 220,000 daltons that is believed to
be a tetramer. This polypeptide resolves to 3 close bands
on a two-dimensional gel (Bock et al., 1984), and has been
postulated to have identical subunits, Mackenzie (1986).
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The enzyme has a pH optimum for catalytic activity of
7.5 and an isoelectric point of 6.8. It has been shown to
have 38% hydrophobic amino acids (Falany et al ., 1 986) and
conjugates p-nitrophenol , estrone, and estradiol (Burchell
and Weatherill, 1981).
Since the molecular weights of estrone and p-nitro-
phenol UDP-glucuronyltransferases isolated from the same
tissue and animal are similar (Tukey et al., 1982), ana¬
lysis of purity based on a single staining protein band may
not be a final proof of homogeneity. However, these trans¬
ferases can be separated based on their substrate selecti¬
vity, pH optima, isoelectric point, amino acid composition,
and peptide fragment profiles after limited proteolysis
(Tukey et al., 1 982).
Rat liver UDPGT has been shown to resist a temperature
of up to 50°C (Norling and Hanninen, 1974) and the glucu-
ronide biosynthesis increases exponentially from 30'’C to
44°C.
Purification and Assay:
Two procedures have been developed to separate and pur¬
ify the enzyme that catalyzes glucuronidation of p-nitro-
phenol by ion-exchange chromatography (Burchell et al.,
1981). Irrespective of the procedure adopted, the enzyme
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is further purified by passing the ion exchange column
fraction(s) through a UDPGA-hexanolamine - Sepharose 4B
affinity column and eluting with the purification buffer
containing 5 mM UDPGA. In addition, UDPGT has been puri¬
fied by chromatofocusing followed by affinity chromato¬
graphy. Homogeneity is assessed using SDS-pol yacrylamide
gel electrophoresis stained with Coomassie Brillant Blue.
The enzyme has been assayed either spectrophotometri-
cally or radiometrically. Spectrophotometrically, UDPGT is
assayed by quantitation of the disappearance rate of the
substrate at 400 nm wavelength (Falany et al ., 1 986).
Radiometrically, the enzymes is assayed by monitoring
the decrease in radioactivity of labelled substrate with
respect to time (Whitmer et al., 1985).
UDPGT Kinetics and Enzyme Mechanisms:
UDP-glucuroni c acid is the required cosubstrate for
all glucuronidation reactions in mammals except cats where
no UDPGT activity has been demonstrated (Hodgson et al.,
1980). It has been shown that the rate of xenobiotic
glucuronidation is dependent on the availability of UDP-
glucuronic acid (Singh et al., 1981).
UDP-glucuronyltransferase exhibits functional hetero¬
geneity according to the aglycone or substrate (Antoine
et. al . 1 983) and the inducing agent (Wishart, 1 978) used.
UDP-glucuronyltransferase activities have been categorized
into three major groups based on preferential induction of
activities towards particular substrates by prototypic
inducers. For instance, it has been shown that phenobar-
bital treatment enhances activities for one group of sub¬
strates typically represented by 2-hydroxybiphenyl, 4
hydroxybiphenyl, phenolphthal ein and morphine. On the
other hand, 3-methylcholanthrene treatment enhances acti¬
vities towards substrates typically represented by p-nitro-
phenol (PNP), 3-hydroxybiphenyl and naphthol (Mackenzie et
al ., 1 985).
Analysis of UDPGT affinity towards aglycones of each
group and towards UDP-glucuronic acid in subcellular mem¬
branes could afford more evidence for the existence of
different molecular forms of UDPGT which would account for
the differences in substrate specificity. Antoine et al.
(1984) have shown that in the endoplasmic reticulum, the
conjugation of group 1 substrates (e.g., 4-nitrophenol) was
at least twice that for group II aglycones (e.g. 1-borneol)
or of an endogenous substrate (e.g., testosterne). In the
golgi and plasma membrane, the different types of aglycones
are metabolized to the same extent.
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The kinetic mechanism of UDP6T activity is a rapid
equilibrium, random bireactant system. Thus, there are two
binding constants for each substrate, one for binding of the
first substrate to the free enzyme (K'uDPGA *^'aglyone)
and the other for binding of the second substrate to enzyme
already saturated with the first substrate (XuDPGA
Kagiycone)* kinetic properties of UDPGT are regulated
via interactions between the enzyme and the phospholipids
of the membrane (Hochman et al., 1981),
Proposed reaction and kinetic schemes for a rapid equi¬
librium, random order mechanism, such as in UDP-glucuronyl-
transferase catalysis, is as follows (Hochman et al,,
1981);
Kb
E + B =====> EB
+ +
A A
EA + B = = = = = = EAB > E + P
akB
E = UDPGT
A = p-nitrophenol or any other substrate {agly-
cone)
B = UDP glucuronic acid
K/\ = Kinetic constant for UDPGT and p-nitrophenol
association
<0 = Kinetic constant for UDPGT and UDPGA associ-
at i on
aK/\ = Kinetic constant for p-nitrophenol association
with enzyme-UDP-glucuronic acid complex
aK0 = Kinetic constant for UDPGA and p-nitrophenol-
enzyme complex association
The dependence of the glucuronidation rate on UDP-glu-
curonic acid concentration in vivo or in isolated cells is
consistent with the observation that the K^ of rat liver
UDPGT for UDP-glucuronic acid ranges from 200 to 500 uM when
the animal is treated with a xenobiotic. This concentration
is above the hepatic UDP-glucuronic acid levels (250-350 uM)
observed in untreated rats (Falany and Tephly, 1983).
The role of UDP-gl ucuroni c acid as the limiting sub¬
strate in glucuronidation has implications in the area of
capacity-1imi ted conjugation (Hjelle, 1 986), UDP-glucuroni c
acid is synthesized in the cytoplasm from UDP-glucose by
UDP-glucose dehydrogenase, as an irreversible, NAD-requir-
ing reaction. UDP-glucuronic acid and NADH inhibit the
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dehydrogenase which ultimately regulates the concentration
of available UDP-glucuronic acid (Fig. 2).
Effects of Phospholipid on UDPGT Activity
It has been proposed that the kinetic properties of
UDPGT are regulated via interactions between it and the
phospholipids of the membrane (Zakim et al., 1975). This
idea was experimentally demonstrated by altering the com¬
position and/or structure of the lipid portion of the
microsomal membrane. In the study, changes in the kinetic
properties of UDP-gl ucuronyltransferase (Zakim and Vessey,
1975) were shown. Moreover, delipidation of a partially
purified preparation of the enzyme leads to a marked dimi¬
nution of activity, which can be restored by adding selected
types of phospholipids (Gorski and Kasper, 1978).
The reconstitution of a delipidated form of UDPGT
appears to require a phospholipid containing a phosphatidyl¬
choline moiety (Erickson et al., 1978). The specific acti¬
vity of the reconstituted enzyme is influenced by the
length and unsaturation of the acyl groups of added phos¬
pholipids. UDP-glucuronyltransferase, thus, is one of
several membrane-bound enzymes regulated by lipid-protein
interactions.
Fig. 2. Enzymes, intermediates and cofactors involved
in UDP-glucuronic acid synthesis and xeno-




















UDP + Glucuronide ^ UDP - Glucuronic Acid
Acceptor (aglycone)
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Inhibitors and Stimulators of UDPGT.
In vitro, the activity of UDP-glucuronyltransferase
has been modulated by the addition of phospholipids, especi¬
ally phosphatidylcholine derivatives (Whitmer et al., 1985).
Pogell and Leloir (1961) described the stimulation of glu-
curonyltransferase activity in rat liver microsomes by the
addition of adenosine triphosphate (ATP), UDP-N-acetyl gl uco-
samine (an allosteric effector) and albumin. Diethylnitro-
soamine and alkyl ketones also activate the purified enzyme
two to three fold when 2-ami nophenol was used as substrate
(Burchell and Weatherill, 1981). According to Burchell and
Weatherill (1981), transferase activity also increases
approximately 30% by the addition of 2 to 20 mM magnesium
i on.
The sulfhydryl compounds p-hydroxymercuric benzoate
and p-chloromercuriphenyl sulfonate inhibit glucuronyl-
transferase activity. The divalent cation Ca^'*' at a con¬
centration greater than 0.5 mM inhibits p-nitrophenyl
glucuronide synthesis, which is reversed by adding 10 mM
EDTA (Isselbacher et al., 1962). Dills and Klassen (1986)
showed that compounds that impair cellular energy product¬
ion such as cyanide and 2,4-dinitrophenol decreased UDPGT
activity by the depletion of ATP in metabolically compro¬
mised cells. This results in decreased synthesis of the
co-substrate UDP-glucuronic acid. Also, modulations in rat
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hepatic microsomal UDPGT activity have been observed during
carbon tetrachloride (CCI4) poisoning, with a large decrease
in the enzyme's cooperativity and an increase in the membrane
fluidity, which may be an early key event in CCI4 induced
liver injury (Deliconstantines et al,, 1986). In addition,
anthranilic acid has been shown to competitively inhibit
p-nitrophenol UDP-glucuronyltransferase (Isselbacher et
al . , 1 962), The end products of the p-ni trophenol UDPGT
reaction (UDP and p-nitrophenylglucuronide) also inhibit
this enzyme (Vessey and Zakim, 1972). Recently Shipley and
Weiner, (1987) showed that adenosine and dibutryl cAMP
inhibit UDPGA accumulation and, ultimately, glucuronidation ,
It has now been demonstrated that at least five rate
controlling factors, (substrate supply, UDPGA levels,
NAD'''/NADH redox state, carbohydrate reserve, and the acti¬
vity of UDPGT) influence glucuronidation in intact cells.
Conditions that alter the cellular level of these factors,
obviously influence UDPGT activity.
Tissue and Intracellular Distribution of UDPGT
Considering that glucuronidation is an important path¬
way in detoxification (Dutton, 1980), tissue and intracell¬
ular location of UDPGT may be important in the chemical
defense against toxins. Using purified IgG from rabbit
antisera against one of the UDPGT isoforms that is known to
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cross react with the other isoforms, the tissue and intra¬
cellular distribution of UDPGT in rat liver, kidney, jejunal
mucosa and adrenal gland have been determined. This dis¬
tribution agrees with the tissue distribution of the enzyme
activity (Roychowdhury et al., 1985),
The kidney has been shown to contribute to glucurondi-
ation of bilirubin in the bile duct of ligated rats and to 3
alpha-glucuronidation of estriol in humans (Mellor and
Hobkirk, 1975). The digestive tract is a major portal of
entry of toxins and carcinogens, and because gl ucuronidation
by the gut markedly reduces the entry of several lipophilic
substances, such as opiates from the gut lumen into the
serum, the presence of the transferase in the mucosal
epithelium may provide a barrier against the entry of
toxins and carcinogens. (Ranee and Shi 11ingford, 1 976),
Glucuronidation of simple phenols occurs throughout the
small intestine; isolated small intestinal mucosal epi¬
thelial cells have been reported to synthesize and glucuro-
nidate bilirubin (Hartman and Bissell, 1982). The presence
of UDPGT activity for simple phenols in the adrenal gland
has been demonstrated. The low levels of the transferase
activity for steroid substrates is consistent with the
UDPGT activity observed in adrenal glands in vivo (Saez et
al., 1972).
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Studies on the distribution of UDPGT in subcellular
fractions of tissue homogenates indicate that the trans¬
ferase activity is concentrated in the microsomal fraction
(Amar-Costec et al., 1974) and nuclear envelope (Beaufay
et al., 1974), Less enzyme activity has been reported in
fractions enriched in golgi apparatus (Hauser et al,,
1984), mitochondria (Schumaker et al,, 1972) and plasma
membrane (Magdalou et al,, 1984), Recently, immunoreactive
UDPGT has been observed exclusively in the endoplasmic
reticulum and nuclear envelope (Roychowdhury et al,, 1985),
Using the same immunocytochemical techniques, no detectable
UDPGT has been observed in the golgi apparatus, lysosomes,
canalicular or sinusoidal portions of the plasma membrane,
and gap junctions.
Earlier, UDPGT had been demonstrated in these organ¬
elles and was claimed to be accessible to antibodies and
immunoreagents (Spater et al,, 1983), Previous reports
of the presence of UDPGT activity in the golgi apparatus,
mitochondria (Schumaker et al ., 1972) and plasma membrane
(Magdalou et al,, 1982) may be due to contamination of these
subcellular fractions by the endoplasmic reticulum. This
disparity can further be explained by the differences in
the assay method and substrates utilized by the investi¬
gators, UDPGTs are glycoproteins (Owens and Mackenzie,
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1984), and the lack of immunodetectabie transferases in the
golgi system may indicate either the glycosylation of these
proteins in other intracellular sites (Atkinson and Lee,
1 984) or a low concentration of the transferases that is
undetectable by the techniques employed,
Xenobiotic Induction of UDPGT
The induction of drug metabolizing enzymes in response
to xenobiotic administration has been well documented.
Several classes of compounds which include polycyclic
aromatic hydrocarbons, barbiturates and steroid hormones
have been identified as inducers of detoxifying enzymes
(Castren and Oikari, 1983). Unlike most inducers, 3-MC
induces both microsomal cytochrome P-450 and UDPGT (Group 2)
concomitantly, probably through a common receptor protein
(Lilienblum et al. , 1982). Recently, Finley et al. (1986)
and Sweeney and Reinke, (1987), confirmed previous studies
that consumption of ethanol greatly enhances the induction
of p-nitrophenol UDPGT as well as many other biotransform¬
ation enzymes. Fischer and Schauer (1985) have shown that
prolonged use of oral contraceptives increases UDPGT in
putative preneoplastic foci in human liver which may be
of prognostic significance in women that use oral contra¬
ceptives.
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Effects of Butylated Hydroxyanisole on Cellular Metabolism
and UDP6T Expression
BHA is a food antioxidant that possesses a variety of
properties of toxicological interest as it prevents oxygen
induced lipid peroxidation (Williams et al., 1986). This
compound has been shown to reduce carcinogenic and hepato-
toxic effects of several structurally diverse compounds
such as polycyclic hydrocarbons, halogenated solvents, drugs
and plant toxins (Wattenberg, 1972; Miranda, et al., 1981).
The protective effects of BHA are thought to be largely due
to its ability to increase the activities of several enzymes
involved in the detoxification of various toxic or carcino¬
genic metabolites. BHA increases hepatic and extrahepatic
activities of glutathione S-transferase(s ) and epoxide
hydrolase and elevates nonprotein sulfhydryl content (Cha
and Bueding, 1979; Stewart and Boston, 1987). It, there¬
fore, has been postulated that the concentration of reactive
and potentially harmful metabolites of polycyclic hydrocar¬
bons, bromobenzene, monocrotaline, and other compounds is
decreased as a consequence of these biochemical changes.
Recently, an increase in an additional phase II bio¬
transformation pathway has been reported to occur in mice
following BHA feeding. Using 4-nitrophenol , 4-ami nophenol,
and 1-naphthol as substrates, the activity of mouse hepatic
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UDP-glucuronyltransferase was significantly increased fol¬
lowing BHA treatment (Cha and Bueding, 1979), BHA has also
been shown to enhance the activity of UDP-glucose dehydro¬
genase (Cha and Bueding, 1982).
The biochemical mechanism by which butylated hydroxy-
anisole increase the gl ucuronidation of xenobiotics has
been examined (Hazelton et al ,, 1 985). Hepatic UDP-glu-
curonyltransferase activity increases toward specific sub¬
strates in native and detergent activated microsomes. In
general, the increase is toward group 1 substrates (1-nap-
thol and p-nitrophenol), whereas no changes are found with
group 2 (choramphenicol) or group 3 (digitoxigenin mono-
digitoxoside) substrates. However, Stewart and McCrary
(1987) recently showed that BHA and 3-MC induced phenol-
phathalien (another group 3 substrate) UDPGT by 2-fold, BHA
treatment increases UDP-glucuronic acid content by increas¬
ing UDP-glucose concentration and enhancing UDP-glucose
dehydrogenase activity (Ordman and Kirkwood, 1977). BHA,
like 3-MC, has been shown to have a more pronounced effect
in female than male mice (Hazelton et al., 1985; Astrom et
al , , 1 986). These observations suggest that BHA increases
the capacity for glucuronidation by elevating both UDP-glu-
curonsyltransferase activities and UDP-glucuronic acid
concentration in liver.
27
Investigation of induction of drug metabolizing enzymes,
especially of the detoxicating enzymes, has shown that speci¬
fic molecular forms of UDP-glucuronyltransferase become
apparent in hepatic preneoplastic cell populations (Sato et
al., 1984), Recently, there are reports implicating BHA
(which induces some of these U0P6T forms) as a cancer causing
agent in the fore-stomach of rats and hamster (Ito et al.,
1983) and as a promoter of urinary bladder carcinogenesis
(Imaida et al., 1983). Therefore, it implies that some of
these BHA induced specific forms of UDP6T may serve as
markers for pre-neoplasm in some animals. The appearance
of forestomach tumors in rats is particularly troublesome
in evaluating potential chemical hazard, since the target
site, the rat forestomach, is absent in man. However,
BHA-associated forestomach tumors appear as early as 3
months in hepatoectomized rats, whereas in intact rats
the appearance of these tumors in seen after a prolonged
latent period of 15-20 months (Abraham et al., 1986).
These opposing effects of BHA could be due to reduced
activation of the carcinogen in the liver and increased ex¬
cretion in the urine of deconjugated metabolites that
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affect the bladder. The possible enhancement of carcino¬
genicity by BHA represents a serious complication of any
anticipated use of this compound to prevent human cancer
(Williams, 1984).
Pathological Aspects of UDPGT
Some pathological conditions have been attributed to
inadequate expression of UDPGT, Deficient hepatic UDPGT
activity has been demonstrated in (a) Gunn rats (Dutton,
1980), (b) Crigler-Najjar syndrome (type I) patients
(Wolkoff et al., 1983), (c) Crigler-Najjar syndrome (type
II) patients (Arias et al., 1969), (d) Gilbertis syndrome
in man (Wolkoff et al ., 1 983), (e) Gilbertis syndrome in
Bolivian squirrel monkeys (Roychowdhury et al., 1982), and
(f) the most common form of deficiency, neonatal unconju¬
gated hyperbilirubinemia in man and monkeys (Gartner et
al., 1977). In these disorders, deficiency in hepatic
UDPGT activity has been demonstrated when homogenates of
microsomes were incubated with UDPGA and bilirubin or
several other glucuronide acceptors (Roychowdhury et al,,
1982; Wolkoff et al., 1983).
Until advanced techniques in UDPGT purification became
available, limited answers were available on the homogeneity,
substrate specificites, effects of microsomal membrane
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phospholipids as well as the specific structural and mole¬
cular defects in disorders characterized by deficiency in
UDPGT activity. Deficiency in hepatic UDPGT function in
humans is readily detected (Roychowdhury et al., 1984) since
affected individuals have non-hemolytic unconjugated
hyperbilirubinemia which is usually severe enough to
produce clinical jaundice. Pathological conditions such as
hyperthyroidism, starvation and experimental diabetes have
been shown to decrease the formation of the obligatory
cofactor UDPGA (Shipley and Weiner, 1987) and therefore,
the formation of glucuronides, These conditions generally
increase tissue cAMP via stimulation of adenylate cyclase.
It is therefore possible that cAMP plays a role in the
alterations seen in glucuronidation under these conditions.
Based on studies with Gunn rat liver microsomes, it
has been suggested that the UDPGT deficiency results from
an autosomal recessively inherited defect in the primary
sequence of UDPGT gene(s) (Wolkoff et al., 1983), Clinical
studies of the various forms of UDPGT deficiency reveal
variation in glucuronidation of different acceptors in vivo
and in vitro. In Gunn rats, for instance, there is a
reduced rate of glucuronidation with phenols compared to
aniline and steroid hormones (Jacobson et al., 1975), which
are reported to be normal. In addition to the Gunn rat, it
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has been shown that patients with Cri gl er-Naj jar type II
syndrome often have other family members who have Gilbert's
syndrome (Wolkoff et al,, 1983). It is possible that the
different molecular defects in altered UDPGT involves
one or more enzyme isoforms, (Irshaid and Tephly, 1 987;
Coughtrie et al., 1 987 ) since it has been speculated that
UDPGTs may be hetero-oligomers in which the various forms
are reconstituted in vivo to form a family of enzymes with
distinct but parti ally overlapping substrate specificity.
Some Molecular Aspects of UDPGT Activity
The molecular mechanisms involved in UDPGT regulation
have rigorously been investigated in several laboratories.
However, these investigations in mammalian tissues are com¬
plicated by the substrate specificity and range of measur¬
able changes of transferase activities in response to
inducing agents (Lillienblum et al., 1982). To circumvent
some of these problems, Burchell et al . (1984) used the
developing chick embryo in the study of the control of gene
expression by drugs and hormones. The activity of hepatic
UDP-glucuronyltransferase towards some substrates is virtu¬
ally absent from chick embryo liver until hatching, when it
rises suddenly to adult values.
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In investigating the transcriptional and translational
events involved in drug-mediated stimulation of UDPGT syn¬
thesis, in 1984 Burchell et al., observed that the preco¬
cious development of UDPGT in chick-embryo liver cultures
was prevented by cycloheximide, which indicates that the
increase of transferase activity was dependent on protein
synthesis. Also, the group showed that mRNA specific for
production of UDPGT accumulated (presumably by synthesis
de novo) in chick embryo liver in response to phenobarbital .
Detailed analysis of the structure, transcription and
genetic defects of UDPGT genes and the turnover of mRNA
require cloned cDNAs coding for UDPGT, Jackson et al,
(1984) for the first time used the expression vector Lambda
gtll as described by Young and Davis, 1 983a,b to isolate
cDNAs coding for UDPGT, Using these cDNAs, they have been
able to estimate the size and content of UDPGT mRNAs.
UDPGT mRNAs are of relatively low abundance in rat liver,
less than 0.1% of the total mRNA (Burchell et al., 1985)
if the animal is untreated.
Mackenzie et al., (1 984a), by polysome i mmunoadsorpti on ,
have enriched for rat liver transferase specific mRNA and
prepared cDNA sequences complementary to this mRNA. Using
the recombinant DNA generated, they determined the size of
the transferase mRNA and the effect of phenobarbi tal and
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3-methyl chol anthrene on the mRNA levels, as well as the
sequence and expression of a cDNA encoding a phenobarbital-
inducible form of UDPGT (Mackenzie, 1986). Recently,
lyanagi et al . (1 986) cloned the 3-MC inducible form of
p-nitrophenol UDPGT, and suggested conserved and variable
regions in the UDPGT isoenzymes.
Research Justification and Goals
At the present time, we are yet to know if BHA and 3-MC
induce different molecular forms of UDPGT, as well as the
mode of expression of the UDPGT genes. However, we do know
that a compound with potential carcinogenic effects (such
as 3-methylcholanthrene, 3-MC) and a compound with "anti¬
cancer" properties such as (butylated hydroxyanisole, BHA)
can induce UDPGT expression in mammals. In addition, the
effect of a simultaneous induction is yet unknown even
though this occurs always in human populations by choice or
accident. Studies in our laboratory have attempted to
determine if there are any differences in terms of cellular
concentration, substrate specificity and kinetic parameters
that exist in the enzyme isolated from rats treated with
these xenobiotics (Stewart and McCrary, 1987).
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From the data obtained, using p-nitrophenol as a sub¬
strate, it seems that BHA and 3-MC have the same stimulat¬
ing effect. However, when animals were treated with both
inducers simultaneously, an additive response was observed.
This may suggest that these two inducers use different
mechanisms to increase the activity of UDPGT. When phenol-
pthalien is used as the aglycone, and UDPGT activity mea¬
sured, all the treatments gave the same response. Since
the combined inducers had no more effect than either com¬
pound used alone, it is inferred that BHA and 3-MC may use
the same mechanism to enhance phenolpthalien UDPGT acti¬
vity (Fig. 3).
Based on UDPGT response to inducers (Wishart, 1978),
the developmental patterns (Wishart, 1978) and tissue
distribution (Bock et al,, 1980) of glucuronidating acti¬
vities, it seems that the forms of this transferase are
regulated in a complex manner. Characterization of the
regulation of this complex enzyme system can be accom¬
plished by examining the mRNA and genes coding for these
forms,
To date information concerned with the molecular mec¬
hanisms of UDPGT expression and genes coding for any
transferase form or post-translational modifications are
not available. Therefore, it is not presently clear if the
different forms of UDPGT transferase are from different
Fig. 3. Effect of xenobiotic inducers on UDPGT activity











genes, or possibly result from the post-translational
processing of a single gene product. This dilemma justi¬
fied the investment of resources and effort in the project
described here. In the long run, this study would be useful
in the elucidation of the genetic, structural and functional
interrelationships among the multiple forms of this enzyme.
The main objective of this investigation was to deter¬
mine the interrelationship(s) between the UDPGT induced by
the carcinogen 3-MC and the antioxidant BHA, so that ulti¬
mately we can understand the mechanism(s) of induction and
regulation of UDPGT and other drug metabolizing enzymes.
The hypothesis was that BHA and 3-MC activate different
genes that express different molecular forms of the enzyme
UDPGT. Because of the multiplicity in the substrate speci¬
ficity of the enzymes obtained from xenobiotic induction,
this investigation was narrowed down to the enzyme forms
that conjugate p-nitrophenol . Here, j_n vitro translation,
cDNA cloning and specific immunoadsorption were utilized to
measure the relationship among the transferases foil owing
butylated hydroxyanisole and 3-methylcholanthrene treat¬
ments .
Specifically, this study was designed to accomplished
the following goals;
1. Purify to apparent homogeneity UDPGT from 3MC, BHA
and 3 MC + BHA treated rat livers.
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2. Raise antisera against p-nitrophenol UDPGT from the
livers of treated rats, and determine immunological
identity,
3. Isolate and characterize p-nitrophenol UDPGT
specific mRNA by:
3) In vitro translation of mRNA from the dif¬
ferent treatment groups.
b) Immunoprecipitation of the UDPGT using
specific antisera.
c) Generation of p-nitrophenol UDPGT cDNA.
d) Cloning of cDNA into plasmids.
e) Screening total rat liver cDNA library to




The female Sprague-Dawley rats used in this investi¬
gation were purchased from Charles River Breeding Labora¬
tories (Wilmington, MA) or bred and provided by Atlanta
University Center, Laboratory Animal Resources. New Zealand
white rabbits were purchased from Hazelton Lab., Denver,
PA. The animal diets with and without butylated hydroxy-
anisole were purchased from Ralston Purina Co. (St. Louis,
Mo). All animals were housed at the Atlanta University
Center Science Research Institute Building (SRI). The
compounds uridine disphosphate glucuronic acid (UDPGA),
UDPGA-agarose affinity resin and para-nitrophenol (p-Np)
were purchased from Sigma Chemical Co. (St. Louis, MO),
and 3-methylcholanthrene was purchased from Aldrich Chemi¬
cal Co. (Milwaukee, Wisconsin). All animals were main¬
tained on hardwood bedding, had access to food and water
libitum, and were kept on a 12 h light-dark cycle.
Goat anti-mouse UDPGT was generously provided by I. Owens
of the National Institutes of Health, Bethseda, MD. The
Lambda gtll rat liver library was obtained from Clontech
Labs, Palo Alto, CA.
37
38
Ani ma 1 5®
There were four treatment groups of at least ten rats
each: untreated; butylated hydroxyanisole treated; 3-methyl-
cholanthrene treated; and butylated hydroxyanisol e plus
3-methylcholanthrene treated groups. On arrival from the
breeders, the rats were kept on an antioxidant free diet
(Control diet) for at least one week. The treatment proce¬
dure was a modification of that described by Fouarge (1986).
In this study, all BHA-treated rats fed on chow that con¬
tained 0.75% (w/w) BHA for two weeks. The 3-MC-treated
rats received two injections of 3-MC in corn oil (ip), 40
mg/kg body weight on consecutive days. The BHA + 3-MC
treatments was a combination of the above two treatments.
At the end of each treatment period, the rats were starved
for 24 h prior to sacrifice by decapitation with a guillo-
tone.
Extraction of Microsomes from Rat Liver Homogenates.
The method described by Tukey et al., (1982) was
employed here. The livers were quickly excised from each
group of sacrified rat, pooled, minced and homogenates (33%
w/v) prepared using 0.05 M Tris-HCl, pH 7.2, containing
0.15 M KCl , and 10% glycerol. Hepatic microsomes were
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isolated by centrifugation. The initial centrifugation was
at 9000 X g for 10 min. The supernatant was collected and
centrifuged at 105,000 x g for 90 min. The supernatant was
aliquoted at 0.5 ml per vial and stored at ■80°C for other
studies. The microsomal pellet was washed with 1.15% KCl
(w/v), then resuspended in 0,05 M Tris-HCl, pH 7.2, contain¬
ing 20% glycerol and 1.0 mM EDTA, aliquoted at 20 mg protein
per 0.5 ml and stored at ■80°C until needed. The amount of
protein was determined by the method of Bradford (1976).
Enzyme Isolation and Purification
The microsomes were solubilized with the nonionic deter¬
gent Lubrol PX (10%, w/w), stirred at 4°C for 60 min and
centrifuged at 105,000 x g for 90 min. The supernatant
was collected and applied to a DEAE-cel1ulose column (Whatman
52) that was equilibrated with 0,05 M Tris-HCl, pH 8,0, The
column was eluted with the purification buffer, 25 mM Tris-
HCl, pH 7,4 containing 0,05% Lubrol PX, 0,1 mM 2-mercapto-
ethanol as described by Singh et al ,, (1981), followed by a
0-500 mM KCl linear gradient elution. Using a modification
of the methods of Singh et al,, (1981); Tukey and Tephly
(1981); Tukey et al., (1982) and Bock et al., (1979), the
peaks with UDPGT activity were pooled, dialyzed against two
changes of the purification buffer overnight at 1.50 liters
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per change, then concentrated with an amicon ultra-filtra¬
tion apparatus (cut off mol. weight of 10,000 daltons).
The presence of protein in the elution fractions was deter¬
mined spectrophotometri cal 1 y at ^o the pooled and
concetjtrated fractions MgCl2 was added (up to 5 mM), fol¬
lowed by application to a UDPGA-agarose column that had been
equilibrated with the purification buffer. The affinity
column was eluted sequentially, first with salt free puri¬
fication buffer, followed by purification buffer containing
50 mM KCl , and finally with the purification buffer contain¬
ing 50 mM KCl and 5 mM UDPGA. Spectrophotomet ri c A28O
readings were obtained for all the fractions, and the peaks
assayed for pNp UDPGT activity, SDS/polyacrylamide gel
electrophoresis was performed on the peaks with transferase
activity to ascertain the number of forms present and the
homogeneity.
Enzyme Assay
With p-nitrophenol as the susbtrate, glucuronyl trans¬
ferase activity was measured spectrophotometrically at
400 nm by modification of the method by Isselbacher et al .
(1962). The incubation system consisted in addition to the
enzyme (100 ug), of 0.25 mM p-nitrophenol , 10 mM EDTA, 5 mM
UDP-gl ucuroni c acid, 5 mM MgCl2; 100 niM Tris-HCl, pH 7.4,
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and 100 ug/ml phosphatidylcholine in a total volume of 0,5
ml. UDP-glucuronic acid was omitted in the control react¬
ions.
The reaction mixtures were incubated at 37°C for 20
min and the reaction stopped by the addition of 1.0 ml
of 3% trichloroacetic acid (w/v, TCA), and allowed to stand
for 5 min on ice (Green et al., 1 985). The reaction
mixture was centrifuged at 1 000 x g for 10 min and the
supernatant solution added to 0.1 ml of 5 N NaOH. The
absorbance was immediately measured in curvettes (1.0 mm
light-path) at 400 nm in a Beckman DU-8 spectrophotometer.
P-nitrophenol UDPGT activity was quantitated by the dis¬
appearance rate of p-nitrophenol (Control A400 “ Expt,
A4oo)* The molar absorption coefficient of pNp (18.8 x
103 cm2/M at pH 9.0) was used to calculate the amount of
p-nitrophenol conjugated.
$0$ Polyacrylamide Gel Electrophoresis and Molecular Weight
determination
Purified UDPGT fractions from the different treatments
were analyzed using 10% sodium-dodecyl sulphate (SOS) poly¬
acrylamide resolving gels and 3% stacking gels. The gel and
samples (15 ug of UDPGT) were prepared according to Laemmli
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(1970). Using the Protean II Bio-Rad gel apparatus, the
samples were el ect rophoresed for 9 h at 3 milliamps per
slot. Staining and destaining of the gels followed the
procedure described by Laemmli (1970).
Approximate molecular weights were determined by com¬
parison of UDPGT migration to relative mobilities of Bio-
Rad low molecular weight standard on Coomassie Brillant
Blue stained gels (Weber and Osborne, 1 968; Ochs et al .,
1981). The molecular weight markers included phosphoryl-
ase b-94K, BSA-67K, oval bumin-43K , carbonic anhydrase-30K ,
soybean trypsin inhibitor - 20K and alpha-1actalbumin
14.4K.
Silver Staining of SDS/PAGE Slab Gels
The methodology was as recommended by the manufacturer,
Bio-Rad in the Silver Stain Kit, Briefly, the gel was
fixed for at least 20 min in 10% methanol-10% acetic acid
(v/v), followed by two separate 30 min fixations in 10%
ethanol-5% acetic acid (v/v).
The fixative was replaced by a 1:10 dilution of the
oxidizer concentrate and the gel was allowed to shake for
10 min. The gel was washed three times for 10 min with
deionized water. The washing was followed by the addition
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of 1:10 dilution of the silver reagent concentrate for 30
min, and then washed for 2 min in deionized water. The
water was discarded, and enough developer (32 g/liter)
added to cover the gel. The gel stayed in the developer
until the solution turned yellow or brown precipitate
appeared. The developer was then poured off and fresh
developer was added for 5 min. This process was repeated
twice. The reaction was stopped with 5% acetic acid (v/v)
for 5 min, before the gel was immersed in deionized water.
The bands were observed under an illuminator, and the
gels stored in zip-lock bags.
Extraction of UDPGT from SDS/PAGE for Anti-sera Production
Bands of interest were visualized in stained prepar¬
ative gels according to Falany et al ., (1 986). The gels
were stained for no more than 30 min and destained for less
than 1 h. The SDS/PAGE bands were recovered individually
by mechanical-elution as described by Sakakibara et al .
(1987), The 57K p-nitrophenol UDPGT was extracted from
a 10% SDS/PAGE gel by cutting out the appropriate band and
grinding in a mortar with pestle for homogenization in 25 mM
Tris-HCl, pH 7.4 and 0.1 mM 2-mercaptoethanol as modified by
Yudelevich et al , 1 973. After centrifugation at low speed
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the gel was re-extracted, and the combined supernatants
were then passed through a millipore filter and eventually
concentrated using an amicon ultraconcentrator. Protein
concentration was determined by the Bradford method (1976).
Antibody Production and Immunological Characterization
Antibody was raised in rabbits against p-nitrophenol
UDPGT from 3-MC treated rat livers, according to the methods
of Pickett et al , (1981) and Singh et al . (1 985). Prior
to immunization with specific antigen (UDPGT), 10 ml of
blood was collected from the ear vein of each rabbit using
butterfly infusion needles. The blood was centrifuged at
2,500 X g and the pre-immune serum collected and stored at
"80°C until needed. Following the pre-immune serum collect¬
ion, about 200-300 ug of the purified enzyme in Freund's
complete adjuvant in a total of 1.0 ml was injected intra¬
muscularly at about 4 sites on the rabbit. Booster injec¬
tions consisting of 100-200 ug of purified enzyme in incom¬
plete Freund's adjuvant was given subcutaneously at approxi¬
mately 7 day intervals for 8 weeks. From the third boost,
2 ml of venous blood was collected to check for antibody
production by double immunodiffusion (Ouchterlony, 1968),
By the seventh or eighth weeks post-immunization, the
rabbits were bled out by cardiac puncture for immune sera
collection as described by Mackenzie et al. (1984b).
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Acepromazine (11 mg/kg body weight) and ketamine (22 mg/kg
body weight) were used to anaesthesize the rabbits before
sacrifice.
IgG was purified from the antiserum by ammonium sul¬
phate fractionation followed by DEAE-cel 1 ul ose chromato¬
graphy and tested by double immunodiffusion (Ouchterlony,
1968) against the specific UDPGT used in its production as
well as the UDPGT from other treatments to ascertain ident¬
ity and cross-reactivity of the antigens. Furthermore,
immunoblot analysis against purified transferases from the
different treatments was performed. To evaluate the re¬
cognition of the functional forms and interrelationships
among the UDPGT from the different treatments, purified
antigens (100 ug) was gently stirred with the specific IgG,
The immune complexes were removed after gentle mixing
(overnight at 4°C) with a Staphylococcal protein A-sepharose
slurry, followed by centrifugation (10,000 xg for 1 min).
After washing the protein A-sepharose beads twice with 0.5
ml of 0.1 M Tris-HCl containing 50 mM KC1, the supernatants
were pooled and UDPGT activity for p-nitrophenol was assayed
(Roychowdhury et al ., 1 985), The study was repeated using
the pre-immune serum for adsorption and inhibition.
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Use of Dot-blot Assay to Titer Anti-UDPGT Serum
Partially purified, mechanically eluted, solubilized
and unsolubilized microsomes containing p-nitrophenol UDPGT
were dot blotted to a nitrocellulose membrane. The membrane
was placed into a blocking solution (3% BSA in 20 mM Tris,
150 mM NaCl , pH 7,5). The solution was gently agitated for
30 min using a shaker platform. The blocking solution
was removed and the membrane washed two times, 5 min each
in TTBS (20 mM Tris, 150 mM NaCl, 0,05% Tween 20, pH 7.5)
on a rocker platform. The wash solution was removed and
different dilutions (0-1:1000) of the anti-UDPGT in TBS +
1% BSA was added. The reaction was allowed to continue for
2 h with gentle agitation. The antibody solution was
removed and the membrane washed two times, 5 min each in
TTBS on a rocker platform. The wash solution was removed
and GAR-HRP (Goat anti-rabbit-Horse Radish Peroxidase
conjugate), the second antibody, was added in the antibody
buffer (1% BSA in TTBS). This reaction was allowed to pro¬
ceed with gentle agitation for 2 h. The second antibody
solution was discarded and the membrane washed two times,
5 min each in TTBS with shaking. The membrane was rinsed
once for 5 min in TBS to eliminate residual detergent. The
membrane was developed in color development solution (4-
chl oro-1-naphthol ) for 30 min with gentle agitation. When
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satisfactory signal (dark blue color) was generated, the
membrane was removed and washed with water. Following the
washing and drying steps, the membrane was scanned with a
densitometer.
Western Blot Analysis
This assay was performed using a modification of the
procedures suggested in Pucci et al. (1987) and the Bio-Rad
manual. Solubilized microsome from 3-MC treated livers was
electrophoretically separated on a 7.5% SDS/PA6E gel as
described by Laemilli (1976). The protein bands in the
polyacrylamide gel were electro-transferred to nitrocellu¬
lose filters overnight at 200 milliampere of current in
a transfer buffer (20 mM Tris-HCl, pH 8.3 and 192 mM gly¬
cerine, 20% methanol) as recommended by Barlow et al.
(1987). The filters were incubated in different dilutions
of the rabbit anti-rat p-nitrophenol UDPGT serum. The
incubations, washings and development of filters after
reaction with the substrate is the same as that of the dot
blot assay described above, except that the densitometric
scan was omitted.
RNA Isolation and Purification
Total RNA from treated rat livers was isolated, ex¬
tracted and purified using a modified guanidium thiocyanate
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method of Chirgwin et al. (1 979) and Spindler et al .
(1984). Briefly, 10 g of minced liver tissue was homo¬
genized in a solution containing 4 M guanidium thiocyanate,
0.5% sodium N-1aurylsarcosine, 0,025 M sodium acetate, pH
7.0, 0,1 M 2-mercaptoethanol and 0,1% antifoam (Sigma). The
RNA was freed of protein by ethanol precipitation or by
sedimentation through 5,7 M cesium chloride (CsCl) followed
by two cycles of phenol-chioroform extraction and etheri¬
zation. The RNA samples were stored in 70% ethanol at
"80°C until needed. Poly(A'*') RNA was isolated by oligo(dT)
cellulose chromatography as described by Aviv and Leder
( 1 972 ) and modified by Krajewska et al , (1 986) with an
intermediate heat step. Briefly, the column was prepared by
resuspending 0.3 grams of oligo (dT) cellulose (Type 3) in
the elution buffer (10 mM Tris-HCl, pH 7,5, 1.0 mM EDTA)
and the column poured and packed by gravity. The column
was washed with 10 bed volumes of the binding buffer (0,5
mM LiCl, 0.2% SOS, 20 mM Tris-HCl pH 7.4). The crude
samples (total RNA) were heated for 2 min at 68°C in sterile
water and then rapidly quenched on ice prior to the addition
of an equal volume of 2X binding buffer and application
to the column. Bound poly(A‘'') RNA was eluted with 10 mM
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Tris-HCI, pH 7,5 and 1.0 mM EDTA. The concentration of RNA
was determined spectrophotometrically, assuming that an
^260 0^ is equivalent to 40 ug/ml of RNA.
cDNA Construction
Double-stranded cDNA was made from enriched transferase
poly(A''') RNA by the methods of Gubler and Hoffman (1 983)
and was inserted into the Pstl site of pBR322-ampi ci 11 i n
sensitive, tetracycline resistant plasmids. Colonies were
selected on TYE agar plates (10 g Tryptone, 5 g NaCl, 3 g
KCl , 2 g yeast extract, 1,5 g Agar) containing 15 ug/ml of
ampicillin and 15 ug/ml tetracycline. The synthesis of the
first strand cDNA was carried out in a reaction volume of
60 ul containing 50 mM Tris-HCl, pH 8.3, 10 mM MgCl2» 10 mM
DTT, 4 mM sodium pyrophosphate, 1,25 mM dGTP, 1.25 mM dATP,
1.25 mM TTP, 0.5 mM dCTP, 50 uCi [32p]ATP (approx. 800
Ci/mmol), 100 ug/ml oligo dT, 150 ug/ml poly(A'^) RNA and
3000 units of reverse transcriptase/ml for 30 min at 43°C,
The reaction was stopped by adding EDTA to 20 mM. The
products were extracted with phenol and precipitated with
ethanol and 2 M ammonium acetate as described by Okayama
and Berg (1982). The amount of first strand synthesized
was estimated by assaying TCA-insoluble radioactivity.
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For second strand synthesis, up to 500 ng of the single-
stranded cDNA (i.e., 1 ug of hybrid) was processed in 100
ul of 20 mM Tris-HCl, pH 7,5, 5 mM MgCl2, 10 mM ammonium
sulfate, 100 mM KCl , 0,15 mM NAD, 50 ug per ml BSA, 40 uM
dNTPs, 8,5 units per ml ^ coli RNase H, 230 units per ml
DNA polymerase 1 and 10 units per ml ^ col i DNA ligase.
The reaction mixture was incubated sequentially for 60 min
at 12®C and 60 min at 22°C, Twenty millimoles of EDTA were
added to stop the reactions. The products were extracted
with phenol twice and then precipitated out of 2 M ammonium
acetate with ethanol. The double stranded cDNA produced
was then ready for tailing (using terminal transferase) and
cloning without further sizing. Plasmid recombinants were
constructed using the double stranded cDNA and pBR322,
Determination of cDNA Yield
The concentration of the actual nucleotide in 50 uCi
of [32p] and [35s] or 200 uCi of [3h] was calculated based
on the specific activity (Ci/mMole) and other information
supplied by the manufacturer. The concentration obtained
was always less than 1.25 mM required for the experiment,
the difference was made up with unlabelled nucleotides
similar to the radioactive nucleotide in other to have
equal concentration of the four nucleotides. The micromolar
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concentration of the radioactive nucleotide was employed in
calculating the specific activity for the first strand
synthesis. Total radioactivity was determined by spotting
2 ul of the reaction mixture at time zero on a Whatman
DE-81 filter paper, air drying and counting in 10 ml aqueous
scintillation cocktail (Beckman Ready-Solv) in a Beckman
scintillation counter.
The change in total counts (delta total count) was
determined by the difference between precipitable counts in
the reaction mixture at the end of reaction and at the
beginning (time zero). Precipitation was done by spotting
2 ul of the reaction mixture on a Whatman DE-81 filter
paper, air drying, soaking in ice-cold 10% Trichloroacetic
acid (TCA) and chilling for about 30 min. The filters
were air dried, washed by vacuum suction three times with
10% TCA, two times with 5% TCA, three times with 95% ethyl
alcohol, and two times with 70% ethyl alcohol (five 5 min
per wash). The filters were again air dried, solubilized
in protosol at 55°C for 30 min before the aqueous scintil¬
lation cocktail was added. Radioactivity was counted on
triplicate samples for 1 min each, and the mean counts per
minute (CPM) was calculated.
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Specific activity was then calculated by the formula
below:
Specific Activity (CPM/ug RNA) =
Total Count (cpm)
Final concentration nucleotide x310 x 4
with radioactivity (Umole)
In the above formula three hundred and ten represents the
average molecular weight of a nucleotide and four stands
for the number of nucleotides.
The change in total counts and specific activity obtain¬
ed above were used to determine the first strand cDNA yield
as indicated below.
cDNA yield (ug) = Change in total count
Specific Activity
The efficiency of first strand cDNA yield was obtained
by the following formula:
Efficiency (%) = First strand cDNA made (ug) x 100
Total mRNA used (ug)
To determine the second strand cDNA yield, the change
in total count was determined as indicated for the first
strand and yield calculated employing the specific activity
obtained for the first strand as follows:
Second strand cDNA yield (ug) = Change in total count (cpm)
Specific Activity (CPM/ug)
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Since the radioactive label was only on the first
strand, the value obtained here was doubled to account for
the double stranded nature of the cDNA at this point.
Here, the percent recovery of cDNA was calculated by divid¬
ing the double stranded cDNA recovered with two times the
first strand yield and multiplied by 100,
ds cDNA Recovery (%) = Double stranded yield x 100
(Fi rst strand yfel'd) x 2
The difference between 100 and the above value accounted
for materials lost in processing the first strand cDNA to
generate the second strand.
Construction of cDNA from Total mRNA for Cloning into pBR322
To amplify specific mRNA expression, the UDPGT enriched
poly(A+) RNA (2.5 ug) used to synthesize the double-stranded
cDNA by reverse transcriptase came from BHA plus 3-MC-
treated rat livers, which has been demonstrated to show
additive UDPGT expression.
The blunt-ended cDNAs generated earlier were elongated
with about 12-18 deoxycytidine residues per 3'hydroxyl end
using terminal deoxynucleotide transferase. The tailed
double stranded cDNA (100 ng) was annealed to 100 ng of pBR
322 cloning vector (New England Nuclear) at the Pstl site as
described by Mackenzie et al., (1984). Figure 4 shows how the
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recombinant plasmid was used to transform E. coli HBlOl by
standard procedures (Maniatis et al. 1982; Okayama and
Berg, 1982 and Gubler et al,, 1983).
cDNA Construction from UDPGT Specific mRNA
To synthesize the first strand cDNA, poly (A'*') RNA (1,0
ug in 20 ul H2O) was placed in a 1,5 ml microfuge tube
after which 1.1 ul of 0,1 M methyl mercury hydroxide was
added, and the mixture incubated for 10 min at room tempera¬
ture. Later on, 2 ul of 700 mM beta-mercaptoethanol was
added and incubated for 5 min at room temperature to inacti¬
vate the methyl mercury. In order, 5 ul of 1 M Tris-HCl, pH
8.7, 7 ul of 1 M KCl, 2 ul of 0.25 M MgCl2, 10 ul of 1 mg/ml
oligo (dT) (12-18), 5,0 ul of a solution containing 10 mM
each: dGTP, dATP, dTTP, dCTP and 5 ul of alpha-C35s]-ATP
were added, followed by 2 ul RNasin (30 U/ul) and 4 ul AMV
reverse transcriptase (10 U/ul), The reaction mixture was
incubated for 2 h at 44°C, and 5 ul of 0.25 M EDTA, pH 8.0,
added to stop the reaction. The reaction mixture was
extracted with 70 ul SS-phenol: chloroform (1:1), mixed by
vortexing, and the phases separated by centrifugation in a
microcentrifuge for 2 min. The upper aqueous phase was
Fig. 4. Schematic diagram of cDNA construction for
cloning into pBR322 plasmid.
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removed and extracted twice with 70 ul of chloroform; 60 ul
of 4 M ammonium acetate were added to the aqueous phase and
mixed thoroughly before 360 ul of 100% ethanol were added.
This suspension was mixed, frozen on dry ice for 30 min
or stored overnight at " 20°C, The cDNA sample was micro-
centrifuged for 10 min at 4°C, the supernatant was dis¬
carded, and the pellet washed with 150 ul of 80% ethanol
that was kept cold but not frozen on dry ice. The micro¬
centrifugation was repeated for 2 min at 4°C, the superna¬
tant removed, and the pellet dried under vacuum. The
pellet was resuspended in 50 ul of TE buffer (10 mM Tris-
HCl , pH 7,4 and 0,1 mM EDTA, pH 8,0), Two ul of sample was
precipitated with 10% TCA, as described earlier and the
filter was counted to determine the amount of [35s]-atP
incorporated into the first strand. The efficiency of mRNA
copying was estimated.
To synthesize the second strand, 50 ul of the first
strand mix was combined with 50 ul of 2 X second-strand
buffer (8 ul 2 M Tris-HCl, pH 7,4, 4 ul IM MgCl2, 8 ul 1 M
ammonium sulfate, 80 ul 1 M KCl , 4 ul nuclease-free BSA (10
mg/ml), 3,3 ul of a mixture of 10 mM each dGTP, dATP, dTTP,
dCTP neutralized to pH 7,0 and 283 ul of H2O, 1,0 ul of
RNase H (2 U/ul) and 2,3 ul DNA polymerase 1 (5 U/ul) were
added. The reaction mixture was incubated at 12°C for
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1 h. To the mixture was added 4,0 ul of 0,5 M EDTA, pH
8,0, and 100 ul of SS-phenol/chioroform (1:1 mix), mixed
thoroughly and microcentrifuged for 2 min to separate the
phases. The upper aqueous phase was transferred to a new
microfuge tube, 100 ul chloroform were added and the sus¬
pension was mixed well and microcentrifuged for 2 min. The
process was repeated before the addition of 100 ul of 4 M
ammonium acetate to the upper aqueous phase. Six hundred
microliters of 100% ethanol were added and the mixture
frozen on dry ice for 30 min before microcentrifugation at
4°C for 10 min. The supernatant was decanted and the
pellet resuspended in 50 ul of H2O and 50 ul of 4 M ammonium
acetate and 300 ul of 100% ethanol were added before freez¬
ing on dry ice for 30 min. The sample was microcentrifuged
at 4°C for 10 min and the supernatant carefully decanted.
To the pellet was added 150 ul of 80% ethanol (kept cold on
ice). The sample was centrifuged for 2 min at 4°C, and the
supernatant was carefully decanted, so as not to disturb
the pellet. The pellet was dried under vacuum and resus¬
pended in 25 ul of autoclaved H2O in a 1,5 ml microcentri¬
fuge tube.
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EcoRl methylation reaction , bl unt end polishing and
digestion to generate cloning ends were performed as
recommended i n Davis et al . (1 986), The second strand
recovery rate was determined by TCA precipitation of 2 ul
of the sample and counting on a scintillation counter with
toluene based cocktail. Figure 5 shows a schematic diagram
for the construction of a Lambda gtll total rat liver cDNA
library.
Polysome Immunoadsorption for Specific UDPGT mRNA Purifi-
catT on.
The procedure described by Kraus and Rosenberg (1982)
was employed here. Polysomes were prepared from the treated
rats by standard methods (El-Dorry, 1986). Briefly, livers
were homogenized in sufficient Tris buffer containing 50 mM
Tris, pH 7,5, 25 mM NaCl, 5 mM MgCl2, 0.25 M sucrose, 1 mg
per ml Bentonite, 0.2 mg per ml heparin and 1 ug per ml eye-
loheximide to make a 15% (w/v) homogenate. The homogenate
was collected and diluted in 0.1 vol of 10% (w/v) sodium
deoxycholate, 10% (w/v) Triton X-100, before layering
(31 ml) over a discontinous sucrose gradient containing
3 ml of 2.5 M sucrose and 1.5 ml of 2.0 M sucrose. Both
sucrose solutions were prepared in a solution of 25 mM Tris
pH 7.5, 150 mM NaCl, 5 mM MgCl2» containing heparin (0.2
mg/ml) and cycloheximi de (1 ug/ml). The sucrose gradient
Fig. 5. Schematic diagram of procedure for generating
double-stranded cDNA species from mRNA, adding
EcoRl ends to the cDNA, and cloning into
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was then centrifuged for 17 h at 26,000 rpm. After centri¬
fugation, the supernatant including the 2,0 M sucrose
layers were aspirated, and the 2.5 M sucrose layers con¬
taining the polysome were added to 1 vol. of a standard
polysome buffer (25 mM Tris, pH 7.5, 150 mM NaCl , 5 mM
MgCl2j 0.1% Nonidet P-40 containing cycloheximide (1 ug/ml )
and heparin (0,2 mg/ml). The polysome solution was dia¬
lyzed against 2 liters of the same buffer for 20 h, fol¬
lowed by a quick freeze in a dry ice/ethanol bath, and
storage at "80°C until needed.
When needed, the polysome preparation was centrifuged
for 10 min at 12,000 x g to remove aggregates and resuspend¬
ed in the polysome buffer to a concentration of 15 A26O
units/ml. Then the polysomes were reacted for 1 h at 4°C
with specific rabbit anti-UDPGT IgG, Protein A sepharose
was prepared, packed in a column that was washed with 1 M
acetic acid and equilibrated with about 120 ml of the
polysome buffer. The flow rate of the column was adjusted
to 5-6 ml per h before the application of the polysome
antibody mixture. The flow-through fractions were quick
frozen and saved for immunopurification of other mRNA
species with different antibodies. After application
of the sample, the resin was removed from the column,
thoroughly resuspended in 2 vol, of polysome buffer, and
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repacked in the same column. The column was washed over¬
night with the purification buffer before elution of the
ribosomal subunits and specific mRNA with the polysome
buffer containing 25 mM Tris, 20 mM EDTA, pH 7,5 and heparin
(0.2 mg/ml ),
Sometimes, polysomal RNA was isolated by a simplified
version of the above process as documented by El Dorry, 1986,
In this procedure, rat liver was minced in 2,5 vol of 20 mM
Tris-HCl, pH 7.5, 5 mM MgCl2» 50 mM KCl (polysome buffer),
containing 0,5 mg/ml heparin. The tissue was homogenizied
with ten strokes using a teflon homogenizer, and centrifuged
for 15 min at 1 200 x g to remove unhomogenized cells, nuclear
materials and mitochondria. The resulting supernatant was
adjusted to 1% each of Triton X-100 and sodium deoxycholate,
loaded at 2 ml/tube on 1,4 M sucrose in polysome buffer
containing 0,5 mg/ml heparin and centrifuged at 45,000 rpm
in a Beckman TY Ti-65 rotor for 150 min. The polysomal
pellet was resuspended in polysome buffer containing 0,5
mg/ml heparin and 0,2 M NaCl , The final concentration of
polysome was adjusted to 50 A26O units/ml and stored at
”80°C in 500 ul aliquots until needed. The polysomes were
sometimes subjected to ^ vitro translation as a check on
the isolation process.
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To isolate, total RNA, the polysomes were incubated at
4°C for at least 1 h with anti UDPGT IgG and eluted with
20 mM EDTA, pH 7,5, containing 0,5 mg/ml heparin.
Isolation of UDPGT Specific mRNA Following Polysome Immuno-
adsorption Using Oligo (dT) Chromatography
To isolate specific poly(A+) RNA, the EDTA eluate was
immediately diluted in 0,5 M LiCl and 0,5% sodium dodecyl
sulfate (SDS) and applied to a 2 ml column of oligo (dT)-
cellulose. The column was washed with 60 ml of the binding
buffer (1 mM EDTA, 0,5 M LiCl, 0,5% SDS and 10 mM Tris-HCl,
pH 7,5), and the bound RNA eluted with the elution buffer
(1 mM EDTA, and 10 mM Tris-HCl, pH 7,5) and then precipit¬
ated at “20°C with 2 vol , of ethanol and 0,05 vol of 4 M
NaCl in the presence of 60 ug of rat liver tRNA (Boehringer
Mannheim),
In Vitro Translation of the mRNAs and Immunoprecipitation
of their Specific UPP^
The specific UDPGT poly (A'*') RNA was translated in
vitro using a nuclease-treated rabbit reticulocyte system
prepared as described by Pelham and Jackson (1976) or using
the reticulocyte translation kit according to the instruc¬
tions of the supplier (BRL Inc,),
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Reticulocyte lysate was obtained from rabbits that had
been made anemic by subcutaneous injection of 1.2% acetyl-
phenylhydrazine for 5 days (Krajewska ^ , 1986), and the
lysate resuspended in 25 uM hemin and 1 mM CaCl2, and then
incubated with micrococcal nuclease (30 ug/ml) for 15 min
at 20°C. After cooling to 4°C, creatine phosphokinase and
EGTA (pH 7,0) were added to a final concentration of 50
ug/ml and 2 mM, respectively, and the lysates stored at
-80°C. The cell free reaction mixture contained 40% (v/v)
of freshly thawed lysate, 2-4 ug/ml poly (A"*") RNA, 0,025 mM
of each of the 19 unlabelled amino acid, 200 uCi/ml of
C35s]-methionine (New England Nuclear, 887-1058 Ci/mMole),
80 mM KCl , 1 mM magnesium acetate, 1 mM ATP, 0,2 mM GTP,
8 mM creatine phosphate and 20 mM HEPES, pH 7,6, The mix¬
ture was incubated for 90 min at 30°C, followed by a cold
25% TCA precipitation for 10 min at 4°C. The precipitated
protein was collected on glass fiber discs (Whatman GF/C)
which were washed with 8% TCA, Prior to determination of
radioactivity, filters were solubilized in protosol tissue
solubilizer (Amersham) and counted in aqueous scintillation
cocktail (Amersham), Total incorporation of labelled
methionine was determined by incubating an aliquot of the
reaction mixture (2 ul ) with 0.5 M NaOH, 0,05% methionine,
0,7% H2O2 for 15 min at 37°C,
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For iinmunopreci pitation of the in vitro translated pro¬
teins, the sample was diluted to 0.2 ml with buffer A con¬
taining 150 mM NaCl , 10 mM EDTA, 0.5% Triton X-100, 2%
methionine, 0,2% SOS, 0.5% BSA, 0.02% sodium azide and 10 mM
sodium phosphate, pH 7.5 and 3 ul of normal rabbit serum
added (pre-immune serum). After incubation of the mixture
at room temperature for 30 min, 30 ul of 10% (w/v) fixed
Staphylococcus aureus cells were added and incubated with
the mixture for 30 min on ice before centrifugation at
10,000 X g for 5 min (Fagan et al, 1983), The pellet was
saved at “80°C and to the supernatant was added 3 ul of
rabbit-anti-rat UDP6T immunoglobulins for an additional
30 min incubation at room temperature before transferring
to 4°C to incubate overnight. The ^ aureus step and
washing was repeated for a second time (Jackson et al.,
1986). To recover the immunoprecipitates, the mixture was
layered over a 1 M sucrose cushion (1 ml) in buffer A and
centrifuged at 10,000 x g for 10 min. The pellet was first
washed with Buffer A and then 150 mM NaCl in 10 mM sodium
phosphate, pH 7,2. The radioactivity was determined by
liquid scintillation spectrometry after solubilizing the
pellet in protosol tissue solubilizers.
To assay for the interrelationships of the p-nitro-
phenol UDPGT forms in cold immunoprecipitated proteins.
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purified UDPGT from different treatments were mixed with
anti UDPGT sera in Buffer A, and incubated in ice for 2 h.
Also, the same sera was used to immuno preci pi tate the i n
vitro translation products labelled with [35$]-methionine.
Furthermore, SDS/po lyac ry 1 ami de gel electrophoresis (10%
resolving and 3% stacking) was performed on the C35s]-iabel-
1 ed translation products, then fixed, dried and the gels
auto radiographed. Before the SDS/PAGE, isolated antigens
were released from the ^ aureus cells by heating at 100“C
for 5 min in sample buffer containing SDS and 2-mercapto-
ethanol (Jackson et al . , 1986), followed by centrifugation
at 40,000 rpm for 60 min at 4°C to pellet the ribosomes.
Autoradiography of In Vitro Translation Proteins
[35$]-methionine labelled proteins were electrophoresed
on 10% SDS/PAGE as described by Laemlli, 1 970, The gels
were dried using Bio-Rad drying equipment and then exposed
at "70°C for two weeks using Kodak XAR-5 film. The cas¬
settes were removed from "70°C and allowed to thaw before
opening. Later on, the films were immersed in the developer
for 5 min, rinsed in water for 2 min and then immersed in
the fixative for 5 min. All films were allowed to air dry
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for about 30 min. Molecular sizes were estimated by
comparison to known molecular weight standards.
Trypsin Digestion of Purified UDPGT from 3-MC and BHA
Treated Rats
P-nitrophenol UDPGT from BHA and 3-MC treatments obtain¬
ed by affinity chromatography were subjected to limited
protease digestion using trypsin. Results from the two
treatments were analyzed on HPLC for differences and simi¬
larities. The peptides generated by proteolysis were ana-
lyzed in 15% acrylamide gels (30.0% by weight acrylamide:
0.8% Bi sacrylamide) as originally described by Cleveland et
al ( 1977) and modified by Tukey et al . (1981). The protein
bands were visualized by placing the slab gel in 4.0 M
sodiurn acetate.
Procedure for Screening Lambda gtll Recombinants Using Poly¬
clonal P-nitropheno1 UDPGT Antibody
E. coli Y1090 (Clontech Lab, Palo Alto, CA) was plated
on 85 mm LB plates (lOg tryptone, 5g yeast extract, 5g sod¬
ium chloride per liter plus 1.5% agar) containing 50 ug/ml
ampicillin as instructed in the Clontech manual. After 18 h
incubation, an isolated single colony was picked and grown
to saturation overnight in LB broth containing 0.2% maltose
(sterilized by autoclaving or filteration in 0.2 urn milli-
pore) and 50 ug/ml ampicillin with shaking. Bacterial
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cells (0.5 ml) from the overnight culture were incubated
with 10 ul of the appropriately diluted Lambda gtll recom¬
binant bacteriophage (Clontech Lab) in the diluent buffer
(10 mM Tris-HCl pH 7.5, 10 mM MgCl2 and 0.1 mM EDTA) for 15
min at 37°C for the phages to attach to the bacterial host.
Following incubation at 52°C, 7.5 ml of soft agar (LB broth
plus 0.75% agar) was added to the culture tube, mixed
gently and poured onto a 150 mm LB plate. The plates were
incubated at 42°C for 3-4 h, after which they were removed
to a 32°C or 37°C incubator and overlaid with dry nitro¬
cellulose filter presoaked in 10 mM IPTG, and allowed
to air dry for 10 min, before overnight incubation.
To check the cDNA library for presence of recombinants,
to the 0.5 ml bacterial cell culture and 10 ul of the bac¬
teriophage mixture mentioned above, were added 3.0 ul X-gal
(10% in DMF) and 3 ul IPTG (100 mM/ml) and incubated at
37°C for 15 min. Then the soft agar was added, the plate
poured, followed by incubation at 42°C as indicated earlier
(Davies et al , 1986). Here, blue plaques represent parental
Lambda gtll with functional beta-galactosidase (1acZ) gene
while clear plaques represent recombinants with defective
1 acZ gene. The recombinant is a hybrid of the cDNA insert
and portions of the 1acZ gene (Fig. 6).
Fig. 6. Illustrative diagram of lambda gtl 1 cloning






























To screen the filters for p-nitrophenol UDP6T specific
clones, the filters were removed from the 37®C incubator,
transferred to a fresh 150 mm petri dish with the side of
the filter that was in contact with the soft agar up, and
rinsed in TTBS (50 mM Tris (pH 7.9), 150 mM NaCl plus 0.05^!i
Tween 20) for 20 min. Later, the filter was incubated
in 10 ml TTBS plus 20% fetal calf serum for 30 min at room
temperature, after which it was removed and rinsed in TTBS.
In binding the primary antibody, the filter was incubated
in 10 ml TTBS plus 1:20 dilution (1 mg/ml) of the rabbit
anti rat p-nitrophenol UDPGT IgG at room temperature. The
filter was then washed in three changes in TTBS, 5 min each
change. For the bound primary antibody to be detected,
goat anti-rabbit IgG conjugated with horse-radish peroxidase
was employed as the secondary antibody. Here, the filter
was transferred to 10 ml TTBS containing affinity purified
secondary antibody that was diluted at 8 ul IgG/10 ml TTBS.
The reaction mixture was incubated at room temperature with
gentle agitation. After 1 h of incubation, the filter was
washed in three changes of TBS (no Tween 20), 5 min each
change. Finally, the nitrocellulose filter was incubated
in 10 ml peroxidase substrate solution (2 ml of 4-chloro-
1-napthol (3 mg/ml) in methanol and 10 ml TBS plus 0.01 M
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imidazole after which was added 5 u1 of 30% hydrogen per¬
oxide) for approximately 30 min. The peroxidase solution
was used immediately after mixing. Before storing the
filter in the dark to avoid bleaching of the positive
stains, it was washed in three changes of distilled water
and air dried.
Prior to usage, the primary antibody (3 ml) was pre¬
adsorbed overnight against a lysate (100 ul) of col i
Y1090 cells as recommended by French et al. (1986). The E.
coli lysate was prepared by resuspending Y1090 cells from
a 100 ml overnight culture in 12 ml distilled water, and
heated in a boiling water bath for 5 min before freezing at
"20°C in 500 ul aliquots. Usually, the primary antibody -
bacterial lysate mixture (after ovemight incubation at
4°C with rotation) was centrifuged at 4000 x g for 10 min
to recover the preadsorbed antibody to be used for immuno-
screening.
Affinity Purification of Antibodies Recognizing Cloned
Protein (Antibody Select)
Antibodies from polyclonal antiserum were affinity
purified as recommended by Barlow et al. (1987) with a few
modifications. Lambda gtll recombinant expressing UDPGT
were grown for 35 h at 42°C, and the plaque proteins
lifted onto 10 mM IPTG impregnated nitrocellulose filters
overnight at 37°C. Before lifting the filters, the plates
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were stored at 4°C for at least 1 h. The filters were
washed with TTBS three times for 5 min each. They were
then blocked with 3% BSA for 30 min at room temperature.
After washing three times with TTBS they were incubated
with a 1:20 dilution of rabbit anti-UDPGT serum for 4 h at
room temperature with shaking. Antibodies that were unbound
were removed by washing three times in TTBS. The last wash
was in physiological saline. The bound antibodies were
eluted with 5 ml per 150 mm petri dish of 0.15 M glycine
hydrochloride, pH 2.3 for 15 min. Here, the agar plates
utilized in growing the bacteria were used after the agar
had been removed and the plate treated with glycine-NaCl pH
2.8 buffer, to prevent antibody from adhering to the plates.
The eluate was neutralized by adding 8 mg Tris/ml eluent
and stored at ■20°C in 500 ul aliquots. Eluted serum was
diluted 1:10 in Western blot assays.
Microsomal proteins (1.0 mg) from different treatments
were fractionated on 7.5% SDS/PAGE with 3% stacking for 10 h
at 75 mA and constant voltage, and el ectropho retic al 1 y
transferred to nitrocellulose membranes at 150 mA overnight
in 25 mM Tris-192 mM glycine-20% methanol. The membranes
were processed as described in the Western blot assay
technique.
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Preparation of Phage DNA
DNA from the positive recombinant clones was prepared
from 150 mm petri-dishes that were plaqued out. Each
plaqued out plate received 7.5 ml of SM buffer and was
incubated for 2 h at room temperature with shaking (Maniatis
et al., 1982). To enhance the migration of the phages out
of the soft agar, a drop of chloroform was added to the
harvested supernatant and incubated at 4°C for 4 h. The
supernatant was treated with 1 ug/ml DNase 1 for 30 min at
37°C. An equal volume of a solution containing 20% (w/v)
polyethylene glycol-6000 (PE6-6000) and 2 M NaCl in SM was
added and incubated for 1 h at 0°C (ice water). The preci¬
pitated phage particles were recovered by centrifugation at
10,000 X g for 20 min at 4°C. The supernatant was removed
and the air-dried pellet resuspended in 0.5 ml of SM by
vortexing. To remove debris, the sample was centrifuged at
8000 X g for 2 min at 4®C, and the supernatant transferred
to an eppendorf tube, after which 5 ul of 10% SDS and 5 ul
of 0.5 M EDTA (pH 8.0) were added before heating at 68°C for
15 min. The sample was extracted once with SS-phenol , once
with phenol/chioroform (1:1), and once with chloroform. In
each case the top aqueous phase was transferred to a fresh
eppendorf tube. To the final aqueous phase was added an
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equal volume of isopropanol, and it was stored at ■70°C for
30 min, then thawed and centrifuged in a microfuge for 15
min at 4°C. The pellet was washed with 70% ethanol, dried
by vacuum and resuspended in 50 ul of TE (10 mM Tris-HCI,




Table 1 shows the effect of the treatments on the
animal weight, liver weight and a ratio of the liver weight
and body weight. Administration of BHA, 3-MC or BHA + 3-MC
to rats resulted in appreciable changes in the animals,
BHA + 3-MC treatment showed an additive effect in liver
weight and body weight compared to either BHA or 3-MC alone,
however, measurable increase in body weight was observed in
all the treatments in relation to the untreated rats. No
detectable difference in liver weight was observed between
the BHA and 3-MC treatments. Hepatomegaly was evident
following all treatments; this was more pronounced in the
BHA + 3-MC treated rats. In addition, hyperlipidemia was
observed in the treated rats compared to the control, which
was more pronounced in the BHA + 3-MC simultaneous induc¬
tion.
The liver versus body weight ratio showed no dif¬
ference in the single treatments of BHA and 3-MC compared
to the control, or between the two treatments. However,
the result for the combined treatment was significantly












Control 262.5 + 18.8 (06.0)* 7.50 2.86
BHA 246.2 + 14.1 (22.0)* 7.44 S.02
SMC 262.8 + SS.l (25.0)* 8.40 S.20
BHA + SMC 260.2 + 12.4 (59.0)* 12.20 4.69
♦Numbers in parenthesis represent change in body weight by
the time of sacrifice.
Values for animal weight and liver are the means for 10
animals.
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P-nitrophenol UDPGT Purification by Ion-Exchange and
AffTmty Chromatography
Solubilized microsomes from untreated control, 3-MC,
BHA and BHA + 3-MC treated rats were fractioned on DEAE-
cellulose (Fig, 7) to partially purify the enzyme. Except
for the control group, four major protein peaks were obtain¬
ed from each treatment, and labelled A, B, C, and D, Peak
B was the missing peak in the control group. Since Peak A
was eluted before the addition of the salt gradient, the
protein(s) in this peak were considered cationic, which
include all hepatic proteins that cannot bind to DEAE-cellu-
lose. The pooled and concentrated peak A fractions had a
brown color which is indicative of the presence of heme
containing proteins, possibly cytochrome.
Peaks B-D were obtained from 0-500 mM KCl salt gradient
elution. These peaks in all treatments, spread from low to
high salt concentrations, and their proteins were referred
to as anionic proteins. The absence of B in the control
group seems to indicate that the low-salt forms are inducer
specific. The BHA and 3-MC + BHA peaks were not as well
resolved on OEAE-cel1ulose as the control and 3-MC peaks.
Following the DEAE-cel1u1ose chromatography, peak A
and peaks B-D were pooled separately for each treat¬
ment, and were identified as non-salt and salt peaks,
Fig. 7. DEAE-cel1ulose ion-exchange chromatography.
Peak "A" is non-salt, and Peaks B-D are
"salt" fractions.
a. Prototype profile showing total protein




















respectively. These fractions were individually applied to
a UDPGA-agarose affinity column and eluted with 5 mM UDPGA
in 50 mM KCl . Figure 8 shows the elution profiles of
control, 3-MC, BHA and BHA + 3-MC salt fractions on affinity
chromatography. Irrespective of treatment, two major peaks
were obtained. The first peak eluted before the addition
of 5 mM UDPGA, and the second peak eluted after UDPGA
addition. Quantitative differences were obtained in the
amount of protein eluting before and after UDPGA addition
among the treatments. When the non-salt peaks were sub¬
jected to UDPGA-agarose affinity fractionation, two major
peaks were obtained as in the fractionation of the salt
peaks (Fig. 9).
Measurement of P-nitrophenol UDPGT Activity
Table 2 shows a typical p-nitrophenol UDPGT activity
profile of the peaks obtained during purification. Although
the data presented here was obtained from BHA + 3-MC treated
animals, similar profiles were observed in the other treat¬
ments. Based on the results that were obtained, there was
minimal p-nitrophenol UDPGT activity in the non-salt frac¬
tions of the DEAE-cel1u 1 ose when the solubilized microsomes
were subjected to this ion-exchange fractionation.
Fig. 8. UDPGA-agarose affinity chromatography of the pooled
"Salt" peaks. Peak 1 is the flow through and peak
2 is the 5 mM UDPGA eluate.
















Fig. 9. UDPGA-agarose affinity chromatography of the
















Table 2. P-nitrophenol UDPGT Activity Profile.
Purification step Apparent Sp. Activity (n=3) Concentration
(umole Pnp/mg Protein/min)mg/ml
Solubilized Microsome 1.369 1.84
DEAE-Cellulose Chromato¬ Peak A 0.129 1.00
graphy (0-500 mM KCl) Peak B 241.369 0.01
Peak C 36.549 0.10
Peak 0 128.268 0.02
UDPGA-Agarose Affinity Flow Through 0.580 0.202
Chromatography 5 mM UDPGA 480.570 0.078
(DEAE-Peaks B-D) Elution
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Most of the p-nitrophenol U0P6T activity was detected
in the intermediate and high salt fractions following 0-500
mM KCl elution. Although peaks B and D had less protein
compared to A and C, there was more p-nitrophenol UDPGT
activity in the former.
When the pooled salt fractions were subjected to UDPGA-
agarose affinity fractionation, minimal p-nitrophenol UDPGT
activity was detected in the flow-through. However, when
the column was eluted with 5 mM UDPGA in 50 mM KCl, about
85% of the activity from the DEAE-cel1ulose fractions was
recovered. Figure 10 shows a flow diagram of the purifi¬
cation scheme and activity distribution.
SDS/Polyacrylamide Gel Electrophoresis and Molecular Weight
Estimation
Following the ion-exchange and affinity chromatograph¬
ies, the proteins were subjected to a 10% SDS/PAGE analysis
to determine the molecular weight of the purified UDPGT.
The ion-exchange non-salt eluates showed two bands, at
estimated molecular weights of 52 and 54 kilodaltons.
Neither of these bands, which were visualized by silver
staining (Fig. 11) were within the documented molecular
weight range of rat liver p-nitrophenol UDPGT (Falany et
al., 1986). Rat liver has been known to have other forms
Fig. 10. A flow diagram of the procedures used for the
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Supernatant Pellet
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Fig. 11. Analysis of the "non-salt" and hydroxyapatite
fractions after affinity purification. Proteins
from different treatments were subjected to 10%
SDS/PAGE as follows:
Lane 1. BHA, affinity purified
Lane 2. 8HA, affinity flow through
Lane 3. BHA + 3-MC affinity purified
Lane 4. BHA + 3-MC, Hydroxyaptite purified
Lane 5. BHA + 3-MC, affinity flow through
Lane 6. 3-MC, affinity purified
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of UDPGT (Tukey et al., 1982). They elute without salt,
and migrate on SDS/PA6E at about 50-54k. Irrespective of
the origin and nature of these proteins, they were observed
in all the treatments. The affinity flow through samples
had protein bands that migrated a little slower than the
two predominant bands that could hardly be visualized on the
gel. Here, we classified these as p-nitrophenol U0P6T or a
related protein that contaminated the non-salt fractions
during ion-exchange chromatography. Although the amount is
relatively small, they may be responsible for the residual
p-nitrophenol UDPGT activity detected in these fractions in
the enzyme assays.
Following the electrophoretic analysis of the non-salt
fractions, the salt samples were analyzed simultaneously
with the non-salts for comparative purposes. The salt
fractions had a major band whose electrophoretic mobility
was less than that of the major band observed in non-salt
fractions (Fig 12), In this analysis, the 5.0 ug/ml of
protein used was not enough to visualize bands on the
coomassie-blue stained gels. However, a minor protein band
that migrated slower than the major band in the salt frac¬
tions was observed. This band was more distinct in the
affinity purified samples.
Fig. 12. 10% SDS/PAGE analysis of "salt" and "non-salt"
fractions.
Salt and non-salt fractions from different levels
of purification were compared on SDS/PAGE to
demonstrate molecular weight differences of the
proteins.
Lane 1 . Molecular weight markers
Lane 2. 3-MC, DEAE (salt)
Lane 3. 3-MC, affinity purified
Lane 4. 3-MC, affinity flow through
Lane 5. Blank
Lane 6. BHA, affinity purified
Lan e 7. BHA, DEAE (salt)
Lane 8. B1 ank
Lane 9. BHA, affinity purified (non-salt)
Lane 10. 3-MC, affinity purified (non-salt)
Lane 1 1 . BHA, affinity purified (non-salt)
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To estimate the approximate molecular weight of these
protein species, affinity purified samples from BHA, 3-MC
and BHA + 3-MC were subjected to SDS/PA6E analysis (Fig,
13). Table 3 shows the relative mobility (Rf) of the pro¬
tein bands (molecular weight markers and purified UDPGT).
From this study, the molecular weights of the salt fraction
major and minor bands were estimated to be 57k and 80k,
respectively (Fig, 14). The value obtained here for the
salt fraction major band is within the accepted range for
rat liver p-nitrophenol UDPGT. At this point, the origin
of the 80k protein and its relationship to the 57k protein
are still unknown.
It has been postulated that UDPGT, in vivo, is a tetra-
mer that may or may not be heterogenous (P, Mackenzie,
personal communication). In order to establish the nature
of the holoenzyme, and possibly the origin of the 80K
protein, affinity purified samples from all the treatments
were electrophoresed on a 7,5% native polyacrylamide gel.
On this gel only one band was observed in each case (Fig.
15), Interestingly enough, the 80k protein was not detected.
This may suggest that the 80k protein is a part of the
holoenzyme, and may have the same origin as the 57k protein,
therefore co-migrating with it.
Fig. 13. Analysis and determination of subunit molecular
weight of affinity - purified UDPGT.
Following affinity purification of UDPGT from
each treatment group, samples were dialyzed
against salt-free elution buffer, concentrated
and analyzed by SDS/PAGE at 20 ug of protein
per lane.
Lane 1 . Molecular weight markers
Lane 2. MC-induced UDPGT
Lane 3. BHA + 3-MC induced UDPGT
Lane 4. BHA induced UDPGT
Lane 5. 3-MC induced UDPGT, affinity
flow through
Lane 6. 3-MC induced, pooled peak from
DEAE-cel1ulose
Lane 7. Molecular weight markers
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Sample Migration Dist. Relative Molecular
(cm) Mobi1ity (Rf ) Weight (k)
Band 1-UDPGT 4.2 0.30 80
Band 2-UDPGT 6.0 0.43 57
Fig. 14. Estimation of rat liver p-nitrophenol UDPGT
molecular weight.
Know molecular weight standards (phosphory-
lase-b, 94k; Bovine Serum Albumin, 67k;
Ovalbumin, 43k; Soybean Trypsin inhibitor,
20k and a1pha-1 actalbumin, 14k) were separated
on a 10% SDS/PAGE, relative mobility determined
and plotted on a semi-log paper against the
known molecular weights. The molecular weight
of UDPGT was estimated from the standard curve
base on its relative mobility.
MolecularW ight
95
Relative Mobility (Rf )
Fig. 15. Native gel analysis of affinity purified UDPGT.
Affinity purified samples (10 ug) from different
treatments were subjected to 7.5% SDS/PAGE
analysis to demonstrate the homogeneity of the











Bio-Rad High molecular weight markers
BHA + 3-MC, affinity purified
BHA, affinity purified
3-MC, affinity flow through
3-MC, affinity purified
BHA + 3-MC, affinity purified "non-salt"
BHA, affinity purified, "non-salt"
3-MC, affinity purified, "non-salt"
3-MC, affinity flow through "non-salt"
Untreated, affinity purified "salt"
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Elution of the 57K Protein from SDS/PAGE for Antibody
Production and Immunological Characteri zati*^
Because of the presence of the 80k protein in the
partially purified sample, the affinity eluates could not
be used directly as a source of antigen for p-nitrophenol
UDPGT antibody production. The 80k protein may have been
removed by gel filtration, but this was not done since it
may have meant losing more of the 57k protein in an extra
purification step. To circumvent possible contamination
from the 80k protein, the salt affinity eluate from MC
treatments was subjected to preparative SDS/PAGE fraction¬
ation. The 57k protein was sliced out and mechanically
eluted from the gel. Protein concentration was quantitated
by the Bradford Method (1976). Two hundred microgram of
3-MC protein in Freund's complete adjuvant was used to
immunize New Zealand white rabbits, followed by 150 ug of
protein in Freund's incomplete adjuvant booster injections
every other week. On the second week, trial serum was
collected to test for the presence of UDPGT antibodies
against the purified protein by Ouchterlony double immuno¬
diffusion (Fig. 16). Antibody against the 57k eluted from
a 3-MC treated animal was detected. When this antibody was
reacted against salt samples from all treatments including
control and an eluted 80k protein, it cross-reacted with
Fig. 16. Ouchterlony double immunodiffusion: Detection
of anti-UDPGT and working dilution determination
The 3-MC 57k protein was used as antigen. The
same dilutions were made of the pre-immune serum
(B).
Center Well. 57k proten
Well 1. 1:100 dilution
Well 2. 1:20 dilution
Well 3. 1:10 dilution





all of them. The reactivity with the 80k protein exhibited
a spur indicating common and variable sequences between the
57k and 80k proteins (Fig, 17). This observation confirms
the initial suspicion that both proteins have a common ori¬
gin. The cross-reactivity with the BHA and BHA + 3-MC pro¬
teins indicates the presence of conserved sequences and
common epitopes on the p-nitrophenol forms of UDP6T from
these treatments. Although no detectable precipitation
line was evident with the UDPGT from the untreated rats,
this does not mean the complete absence of these proteins,
since the double immunodiffusion assay is not very sensi¬
tive.
Having established the presence of p-nitrophenol anti¬
body in the serum, the animals were anaesthesized with a
mixture of acepromazine (1.1 mg/kg body weight) and ketamine
(22 mg/kg body weight) and bled out by cardiac puncture.
The serum was ammonium sulfate precipitated and DEAE-cellu-
lose fractionated (Fig. 18), Three peaks were obtained on
the ion-exchange fractionation. The anti-p-nitrophenol
UDPGT peak was determined by double immunodiffusion. Most
of the anti-p-nitrophenol UDPGT reactivity was located in
peak B (Fig. 19).
Antibody titer was determined by double immunodif¬
fusion and later repeated using immunoblot (dot and Western
blottings). In the Ouchterlony assays, no precipitation
Fig. 17 Ouchterlony double immunodiffusion analysis of
affinity - purified UDPGT from treated and
untreated rats against anti-MC UDPGT.
UDPGT isolated from different treatment groups
and the untreated was tested against rabbit anti
MC UDPGT serum. The center well contained
anti UDPGT.
Well 1. PBS
Well 2. UDPGT from untreated rats
Well 3. UDPGT from MC-treated rats (the 57k
protein extracted from a 10% SDS/PAGE
Well 4. The 80k protein extracted from a 10%
gel
Well 5. UDPGT from BHA + 3-MC treated rats
Well 6. The "non-salt" peak obtained from
the DEAE-cel1ulose chromatography
of the MC solubilized microsome.
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Fig. 18. OEAE-cel1ul ose purification of rabbit anti¬
rat UDPGT serum.
Serum from rabbit that was immunized with
the 57k protein from 3-MC induced rat was
separated on DEAE-cel1ulose, and eluted
with 0.0175 M phosphate buffer, pH 6.3.
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Fig. 19. Ouchterlony double immunodiffusion analysis
of DEAE-cel 1 ulose purified anti UDPGT.
The three proteins peaks obtained from
DEAE-cel1ulose purification were analyzed
by double immunodiffusion to ascertain
the peak that has anti-UDPGT activity.
Center well had the 3-MC 57k protein
Wei 1 1. PBS contro1
Well 2. Peak A
Well 3. IJnpurified serum




line was observed beyond a 1:10 dilution of the whole serum
while a 1:100 and 1:200 dilutions were the limit of the
dot and western blots respectively, based on the positive
signals observed after a goat anti-rabbit - horse radish
peroxidase reaction. Figure 20 shows a western blot ana¬
lysis of the anti-UDP6T against total rat liver microsomes.
A densitometric scan of the dot blot did not show any
interpretable data beyond th« 1:20 dilution of the antibody
(Fig. 21). Based on the titration information obtained,
a 1:5 dilution was used as the working dilution in sub¬
sequent double immunodiffusion assays, and 1:200 was used
in immunoblot assays.
To evaluate the topology of UDPGT on the endoplasmic
reticulum membrane, dilutions of the antibody were reacted
with solubilized and unsolubilized microsomes, affinity
purified proteins from all the treatments including untreat¬
ed via Ouchterlony immunodiffusion and dot blot assays
(Table 4). The solubilized microsomes and the affinity
samples reacted as expected. However, the reactivity
obtained with the unsolubilized microsomes indicated that
UDPGT is a transmembrane protein. Figure 22 shows an immuno¬
diffusion analysis of the unsolubilized microsomes. It
seems that the portions outside the membrane contain epi¬
topes that are conserved in the different forms of this
Fig. 20. Western blot analysis of solubilized microsome
from 3-MC treated rats.
Different dilutions of solubilized microsome
(1.0 mg; 0.75 mg; 0.50 mg and 0.25 mg) were
separated on a 10% SDS/PAGE. The proteins were
electrotransferred to nitro-cel1ulose and
processed with different dilutions (1:20; 1:200
and 1:1000) of rabbit anti-rat UDPGT serum.
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Fig. 21. Dot-blot analysis and densitometric scan from
different treatment groups.
UDP6T from different treatments was added to
wells in a 96-well microtiter plate as follows:
Columns A and B had untreated UDP6T; C and D
had 3-MC UDP6T; E and F had BHA UDPGT, G and H
had BHA + 3-MC UDPGT. The samples were dot
transferred to nitrocellulose by vacuum suctioning.
The nitrocellulose filters were treated with
rabbit anti rat UDPGT serum followed by goat
anti-rabbit IgG-HRP conjugate. Different dilutions
of the antiserum were utilized as follows:
Row 1. Undiluted serum (A)
Row 2. 1:10 serum dilution (B)
Row 3. 1:20 serum dilution (C)
Row 4. 1:100 serum dilution (D)
1:1000 serum dilution (E)Row 5.
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WELLS
Fig. 22. Ouchterlony double immunodiffusion of unsolu
bilized microsome against anti-UDPGT serum.
Microsomes from different treatments (50 ug)
were immune reacted against anti-UDPGT serum
Center well had rabbit anti-rat 57k protein.
Well 1. PBS control
Well 2. 3-MC microsome
Well 3. Blank
Well 4. BHA microsome
Well 5. B1 ank
Well 6 BHA + 3-MC microsome
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Solublized Control Microsome + ++
Solublized 3-MC Microsome ++ ++
Solublized BHA Microsome ++ ++
Solublized 8+M Microsome +++ +++
Unsolublized 3-MC Microsome + ++
Unsolublized B+M Microsome + ++
Affinity Purified PNp-UOPGT (Control) ++ ++
Affinity Purified PNp-UDPGT (3-MC) +++ +++
Affinity Purified PNp-UOPGT (BHA) ++ ++
Affinity Purified PNp-UDPGT (B+M) +++ +++
SDK Extract from Purified 3-MC + NO
+ = Fairly Intense Reaction
++ = Intense Reaction
+++ = Very Intense Reaction
= No Reaction
NO = Not Determined
Fig, 23. Immunoprecipitation of UDPGT activity from
reaction mixtures with anti-MC-UDPGT,
Series of enzyme reactions were performed
in which affinity-purified UDPGT from each
treatment group served as the source of
enzyme and p-nitrophenol was the substrate
used. The percent of anti-MC UDPGT was
steadily increased as denoted and the amount




enzyme, and as such could be recognized by antibody made
for all forms of the enzyme. The reactivity obtained with
the untreated samples was not as intense as those obtained
with treated animals. Once again, this is more of an
indication of the degree of induction and sensitivity of
the assay instead of the nonexistence of this enzyme in
untreated animals.
Inhibition of P-nitrophenol UDPGT Activity with Rabbit
Anti-57k Serum
Since we know that UDPGT generally exists in multiple
forms, and the immunological data obtained here seem to
indicate the presence of conserved antigenic determinants
on the enzymes from different treatments, it was necessary
to deduce the effect of the antibody on the p-nitrophenol
UDPGT activity. Secondly, we had to establish that the 57k
protein isolated is the enzyme that catalyzes the conju¬
gation of p-nitrophenol to UDP-glucuronic acid. Another
important aspect of this study was to demonstrate the
relationships among the enzyme from different treatments,
considering that the antibody was made against the 3-MC
induced 57k protein. To illustrate the specificity of
the antibody for p-nitrophenol UDPGT, the experiment was
repeated using a rabbit pre-immune serum.
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The results (Fig, 23) show that the pre-immune serum
could not inhibit the activity in the reaction mixture.
About 85% of p-nitrophenol UOPGT activity was retained,
irrespective of the treatment and possible enzyme form.
However, significant reduction was observed in all the
treatments using the specific antisera. The antibody was
able to eventually absorb out and inhibit close to 95% of
the activity in the reaction mixtures.
To quantitate the inhibition obtained by the immuno-
precipitation, the amount of antiserum required to cause
50% inhibition was used as a reference point. It was noted
that 20% suspension of the antiserum was required to cause
50% inhibition of the MC-induced UDPGT activity, however,
for the same amount of inhibition of the control, BHA and
BHA + 3-MC-induced enzymes, the amount of antiserum was 41%,
28% and 32%, respectively. The differential inhibition
observed here may reflect the existence of variable amino
acid sequences on the different forms of the enzyme. The
difference observed between the inhibition of the treated
and untreated samples may be indicative of existence of
inducer specific forms of UDPGT, This observation may
explain the absence of one of the three salt peaks in the
DEAE-cel1u1ose fractionation of the untreated samples.








Immunological Comparison of Rat and Mouse UDPGT
Now that we had established that p-nitrophenol UDPGT
from different treatments are immunological 1y identical with
subtle variable sequences, it was essential to know if this
was a species specific reaction. Goat-antibody against
mouse UDPGT (from Dr. Owens, N.I.H) was reacted against the
partially purified proteins from the treated animals in an
immunodiffusion assay and there was cross-reactivity (Fig.
24). Even though similarities have been demonstrated
among the enzymes from different treatments, UDPGT from
different species also have conserved sequences.
Tryptic Digest Analysis of UDPGT from Different Treatments
Based on the enzyme immunoabsorption assays in which
differential inhibition was noticed, and to verify the
possibility of variable sequences on the p-nitrophenol
UDPGT from different treatments, the purified enzymes were
trypsin digested and the digestion pattern evaluated using
HPLC. We were unable to detect the proteolytic fragments
by SDS/PAGE. On HPLC, the digestion pattern for the 3-MC
and BHA proteins showed regions of identity and some vari¬
able regions (Fig. 25). These data gave credibility to the
immunological observations which showed cross-reactivity
among the different forms, but differential response to the
anti body.
Fig. 24. Double immunodiffusion analysis of goat anti¬
mouse UDPGT and rabbit anti-rat UDPGT against
affinity purified rat liver p-nitrophenol
UDPGT.
UDPGT from different treatments was reacted
against anti-mouse UDPGT serum to demonstrate the
interrelationship between rat and mouse UDPGT.
Center well (A) = Rabbit anti-rat UDPGT (whole
serum). (B) = Goat anti-mouse UDPGT (Ammonium
Sulfate ppt).
Well 1. A and B. 3-MC, affinity purified UDPGT
Well 3. A and B. BHA, affinity purified UDPGT
Well 5. A and B. BHA + 3-MC, affinity purified
UDPGT
The rest of the wells were blank
113
Fig. 25. Tryptic digest analysis of UDPGT from 3-MC
and BHA induced rats.
Fifty microgram of UDPGT from BHA and 3-MC
induced rats were trypsin digested, and the
fragmented separated on HPLC.
A. 3-MC, affinity purified
B. BHA, affinity purified
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mRNA Isolation and Characterization
Consistently, we have observed an elevation of the
UDPGT activity in induced animals. It was essential at
this point to know if the increase in enzyme activity was
due to the activation of pre-existing enzymes or activation
of the gene by the inducers. In addition, we needed to
confirm that the 57k protein could be obtained from in
vi t ro translation and how it compared with the native i n
vivo translated protein. Poly(A'‘‘) RNA was obtained by the
guanidine thiocyanate method from a BHA + 3-MC treated rat
liver (Table 5). From lOg liver tissue, 50 ug/ml of mRNA
was isolated. Here, we noticed an 80% increase in the
amount of total RNA in induced compared to 20% in uninduced
animals (Fig 26). The initial indication is that the
elevated activity may be a transcriptional phenomena instead
of a post-translational event.
The _i_£ vitro translational assay was performed with
2.0 ug of the poly(A+) RNA in nuclease treated rabbit retic¬
ulocyte. Dog pancreatic microsomes were added to the react-
tion mixture to simulate the jji vivo processing conditions
in which pre-UOPGT is cleaved to mature UDPGT by removing the
signal sequences. The reaction mixture was immunoprecipit-
ated using rabbit antibody against 57k p-nitrophenol UDPGT,
followed by protein A-sepharose precipitation. Table 6
shows [35$]-Methionine incorporation that was measured using
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Table 5: Poly (A*) RNA Isolation




ug/ml % Recovery t Efficiency
Guanidlum Thiocyanate Extract 2.280 2.744 0.831 1:100 9120 100 100
Phenol Extract 2.160 2.622 0.824 1:100 8640 95 95
Cesium Chloride Pellet 2.019 2.576 0.784 1:100 8436 93 98
First ETOH Precipitate 0.426 0.262 1.626 1:100 1704 19 20
Second ETOH Precipitate 0.408 0.274 1.489 1:100 1632 18 96
Oil go (dT) Fraction 0.639 0.476 1.342 1:10 256 3 16
Oil go (dT) Phenol Extract 0.126 0.087 1.448 1:10 50 0.5 20
Fig. 26. Isolation of total hepatic RNA from each
treatment group.
The quantity of total hepatic RNA was deter
mined for each group using lOg of tissue.
RNA was quantitated based on the assumption





Table 6. In Vitro Translation and Immunoprecipitation of Rat Liver
l^nitrophenol UDPGT (BHA + 3 MC mRNA).
Sample Total CPM CPM after Immunoprecipitation
Total Rat Liver mRNA 5749 1395
Globin mRNA 3760 240*
*Globin mRNA in vitro
p-nitrophenoT~UDPGT,
translation was immunoprecipitated with anti-
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a scintillation counter. Here again, the antibody was able
to precipitate out the 80k and 57k as the major proteins in
both the in vivo translated samples. (Fig. 27a), Only the
57k of in vitro translated sample that had C^Ssj-methionine
incorporated was detected in the autoradiogram (Fig. 27b),
The 2_n vitro translated sample with dog pancreate microsome
had the same electrophoretic mobility as the 57k protein
of j_n vivo translated samples (Fig, 27a). The initial
indication was that the 57k protein is a bonafide rat liver
protein whose mRNA is represented in the population of mRNA
we have isolated. With this total rat liver mRNA, we were
ready to construct cDNA for library generation.
To further demonstrate that increased activity in
induced animals was a transcriptional event, we isolated
poly(A‘*') RNA from the livers of untreated, BHA, 3-MC and 8HA
+ 3-MC treated rats. The data correspond stoichiometri-
cally with the enzyme activity and protein accumulation
results, BHA + 3-MC showed an additive accumulation of
poly(A'‘’) RNA compared to either 3-MC or BHA alone (Fig, 26),
This is further evidence that gene activation is involved
in the observed over expression of UDPGT mRNA.
Fig. 27a. Comparison of in vitro and in vivo translated
UDPGT.
Poly(A‘'') RNA was isolated from a BHA + 3-MC
treated rat, and 2.0 ug was used in cell-free
protein synthesis in the presence of dog
pancreatic microsomes, and [35s]Methionine.
In Vitro translated as well as jjn vi vo
translated UDPGT were immunoprecipitated, and







Iri vi VO 3-MC UDPGT
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cDNA Construction from Total mRNA and Cloning into pBR322
By the reverse transcriptase method, single stranded
cDNA was constructed from the isolated total rat liver
poly(A'*‘) RNA that was isolated from BHA + 3-MC treated
rats. From 10 ug of polyCA'*’) RNA in a 50 ul reaction
mixture, 0.910 ug of single stranded cDNA was obtained for
an efficiency of 9% (Table 7). Using 0.91 ug of the first
strand cDNA, 0.63 ug of the double stranded cDNA was gener¬
ated for a recovery rate of 69%. This double stranded cDNA
was d(C) homopolymer tailed using terminal deoxytransferase
and cloned into the Pstl site of pBR322 that has been
tailed with poly d(G). Following phenol-chioroform extrac¬
tions and ethanol precipitation, the pBR322 carrying these
cDNA inserts were used to transform E. coli HBlOl which was
plated on TYE agar that contained 15 ug/ml tetracycline.
The plates were incubated for 48 h and the colony forming
units counted. The number of transformants observed was
not above background (Table 8), and the transformation
efficiency was relatively low. Based on this result, we
decided to repeat the process using the expression vector
(Lambda gtll) instead of pBR322 and for the ease of screen¬
ing the library that may be generated. Furthermore, we
chose to use specific mRNA isolated by polysome immuno-
adsorption instead of total rat liver mRNA hoping that our
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Table 7. Total Rat Liver cDNA Synthesis
Starting Yield Efficiency
Sample Concentration (ug) CPM (ug) (%)
Poly(A+) RNA 10.0 165 - -
Single Strand cDNA 10.0 2.76 X 106 0.0914 9.14
Double Strand cDNA 0.910 2.39 X 105 0.632 69
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Table 8. Total Rat Liver cDNA Library Production: Plasmid pBR-322
Transformation of E. coli HB 101
Treatment Colony Forming Units (CFU/ml)
HB 101 Inoculum 8.0 X 105
Culture at Harvest 1.0 X 108
Competent Cell without DNA <10
Uncleaved pBR322 (100 ug) 1.0 X 102
Cleaved pBR322 (G-tailed) <10
pBR322 - Rat Liver cDNA Chimera 0.7 X 10l
pBR322 - Globin cDNA Chimera 0.5 X lOl
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chances of isolating the clones carrying the p-nitropheno1
UDPGT gene would be increased.
Isolation of Poly(A'*') RNA by Polysome Immunoadsorption
If the induction that has been observed in this study
is a transcriptional event, some difference should be
observed in the level of polysome obtained from the dif¬
ferent treatments. Using a modification of the Kraus and
Rosenberg ( 1982 ) technique as was described by El Dorry,
(1986); Giachelli and Omiecinski (1987), polysomes were
isolated from 5 g of rat liver of all the treatments and the
untreated. The level of polysomal RNA accumulation was
consistent with the level of protein and specific enzyme
activity that was observed earlier. Statistically, there
was no significant difference between the level of induc¬
tion obtained from BHA treatment compared to 3-MC (p <
.01). However, a synergistic accumulation of polysomal
complex was observed with the BHA + 3-MC treatment compared
to the single treatments as shown in Fig. 28. The treated
samples showed more polysomal complex accumulation than the
untreated control. This result further substantiates that
these xenobiotics can modulate gene expression.
Fig. 28. Isolation of polysomes from rat liver of each
treatment group.
Homogenized rat liver tissue (5 g) from each
treatment was loaded onto 1.4 M sucrose and
centrifuged. The polysome pellet was resuspended
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From these polysomes, UDPGT specific mRNA was isolated
by immunoadsorption, followed by repeated cycles of oligo
(dT) chromatography. Specific poly(A''') RNA from a 3-MC
treated rat was used in an j_n vitro translation assay and
compared to total poly(A''') RNA from all the treatments.
The translation mixture was subjected to immunoprecipitation
before application to a 10% SDS/PAGE analysis.
The result showed two major protein bands for all the
samples irrespective of the treatments or the source of the
mRNA. The low and high electrophoretic mobility bands were
estimated to be about 60k and 52k respectively. A minor
protein band was also observed in the 82 - 84k range (Fig.
29), The 60k and 83k protein bands obtained here are
consistent with the 57k and the 80k protein obtain from the
in vivo translated samples considering that these samples
were neither glycosylated nor processed to cleave the
signal sequence. The 52k protein obtained here was inter¬
preted to be another form of UDPGT as was noticed when the
in vivo translates were affinity fractionated and SDS/PAGE
analysed. When this result was compared to samples that were
not immunoprecipitated, these bands were not as pronounced,
using coomassie blue stain. The intensity of the bands
was increased by silver staining. Even though the inten¬
sity of the bands was not as pronounced, more protein bands
Fig. 29. SOS/PAGE analysis of cell-free synthesized and
immunoprecipitated UDPGT.
Poly(A'‘') RNA was extracted from the liver of
a rat in each treatment group and used for
in vitro translation in the presence of
[35s]-methionine. Anti-MC-UDPGT was used for
all immunoprecipitation. Lanes were as follows:
Lane 1. Molecular weight markers
Lane 2. BHA + 3-MC, UDPGT polysomes
Lane 3. BHA + 3-MC, translated from poly(A''‘) RNA
Lane 4. BHA UDPGT, from poly(A+) RNA
Lane 5. 3-MC UDPGT, poly(A+) RNA
Lane 6. Immunoadsorbed polysome: Poly(A‘'') RNA
extraction (3-MC UDPGT specific mRNA)
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were observed compared to the immunoprecipitated. It seems
from these data, that the immunoprecipitation utilized above
selected against the non-UDPGT proteins, thereby making it
possible for us to concentrate the p-nitrophenol UDPGT in
these samples. The precipitated and non-precipitated sam¬
ples that had been el ectropho resed on 10% SDS/PAGE were
subjected to autoradiography to detect the protein bands
with [35$]-methionine labels. More low molecular weight
proteins were observed in the unprecipitated samples which
were not detected in the precipitated samples (Fig. 30).
These proteins are outside the accepted molecular weight
range for p-nitrophenol UDPGT and are not recognized by the
polyclonal antibody raised against the 57k protein which has
been demonstrated to react with other forms of UDPGT because
of the conserved nature of the protein family.
To demonstrate that the differential accumulation of the
polysomal complex in these treatments correlates with the
amount of specific poly(A+) RNA that could be induced,
mRNA was isolated from these polysomes and purified by
oligo (dT) chromatography. Fig. 31 shows the differential
induction of UDPGT specific mRNA according to treatments.
While no considerable difference was observed between the
mRNA obtained from BHA or 3-MC treated animals, an additive
induction was obtained from the BHA + 3-MC treated animals.
Fig. 30. Autoradiogram of in vitro translated, but
non-immunopreci ptated poly(A‘*’) RNA from
treated rats.
Poly(A'*’) RNA was isolated and in vitro
translated without dog pancreatic micro-
some. [35s]methionine was used to label
the proteins. SOS/PAGE was performed,
the gel dried and autoradiographed,
Lane 1. BHA + 3-MC, polysome
Lane 2. BHA + 3-MC, poly(A+) RNA
Lane 3. 3-MC, poly(A+) RNA
Lane 4. BHA, poly(A+) RNA
Lane 5. 3-MC, polysomes
Lane 6. 3-MC, UDPGT specific poly(A‘*’) RNA
Lane 7. BHA, polysome
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Fig. 31. Isolation of UDPGT specific mRNA by polysome
immunoadsorption.
Isolated polysomes were reacted with anti-
UDPGT and the binary complex loaded onto Pro-A
sepharose. The total polysomal RNA was eluted





























These data further validate the statement that increased
enzyme activity observed earlier was not an activation
event, but rather a result of gene expression*
cDNA Synthesis from UDPGT Specific mRNA
Double stranded cDNA was constructed starting with
1.0 ug of mRNA from each treatment, using globin mRNA as a
positive control. The first strand was labelled with
C35s]-ATP and the total count was about 1.50 x 10^ CPM. The
average specific activity was 2.74 x 10^ cpm/ug RNA, 2.66 x
10^ cpm/ug RNA, 1.80 x 10^ cpm/ug RNA and 2.48 x 10^ cpm/ug
RNA for BHA, 3-MC, BHA + 3-MC and globin control, respect¬
ively, The first strand synthesis efficiency was 9,0%,
12.1%, 17.4% for BHA, 3-MC and 3-MC and BHA + 3-MC, respect¬
ively, These results were comparative to the efficiency
obtained with globin mRNA (10,2%), Table 9 shows a compar¬
ative illustration of the synthesis of cDNA and the yield
from the treatments.
When the first strands were used as template to syn¬
thesize the second strand, the percent recovery was 78,69,
62 and 83 for BHA, 3-MC, BHA + 3-MC and globin, respective¬
ly, These numbers were within the expected range for
second strand cDNA synthesis.
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Ut Straiul 2nd Strand








BHA 1.70 X )0^ .099 X to? 2.47 X to* 0.090 9.00 1558 1.94 X 10* 0.142 78.0
3-MC I.6S X lO' .129 X to* 3.22 X to* 0.121 12.10 1803 2.25 X 10* 0.169 69.0
BHA * 3-MC ).I2 X 10' .126 X I0« 3.14 X to* 0.174 17.40 1553 1.94 X 10* 0.216 62.0
Glouin 1.54 X 10^ .101 X to* 2.53 X to* 0.102 10.20 1686 2.11 X 10* 0.170 83.0
NOTE: SO uCI/S ul of C^H]-ATP (800 cl/fflHolo) was used In each 60 u1 reaction mixture.
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Furthermore, these cDNAs were methylated with EcoRI
methylase so that they could be used to clone into the
EcoRl site of Lambda gtll to generate a rat liver cDNA
1 ibrary.
Screening the Rat Liver cDNA Library for UDPGT Clones.
About 200,000 lambda gtll plaques were screened to
isolate the clone(s) carrying UDPGT inserts. We obtained
thirty-five positive clones. By a random check, one out of
every three (33%) of these turned out to be true positives
after they have been plaque purified (Fig. 32). DNA has
been isolated from these phages which are to be character¬
ized in future experiments to determine the insert size and
their identities in terms of the gene product expressed.
Selection of Monospecific Antibodies Recognizing UDPGT cDNA
Carrying Recombinants and Western Blotting
Since the antibody we generated cross-reacts with all
UDPGT forms, 3-MC UDPGT specific antibodies were purified
from the polyclonal antiserum by the antibody select techni¬
que of Barlow et al . (1987). The affinity purified anti¬
bodies were used to analyze solubilized rat liver micro¬
somal proteins that had been separated by SOS gel electro¬
phoresis. The antibodies recognized only UDPGT from 3-MC
Fig. 32. Immunoscreening and plaque purification of
Lambda gtll cDNA library.
Lambda gtll cDNA library was screened to select
those clones with UDPGT inserts. The positive
plaques were plaque purified to select (A) true




and BHA + 3-MC treated animals. This suggests that the
population of antibodies that recognized 3-MC forms of
p-nitrophenol UDPGT were selected (Fig. 33) as opposed
to those that recognized the BHA forms. The intensity of
the positive bands was more pronounced in the combined
induction of BHA + 3-MC compared to 3-MC alone, which is
consistent with earlier results obtained when enzyme acti¬
vity, protein accumulation and specific mRNA were evaluated.
Moreover, two major bands that are 57K and 52K were obtained
from the positive reactions, which correspond to the anionic
and cationic forms of UDPGT that were demonstrated in the
enzyme purification analysis. The ability of these mono-
specific antibodies to select against BHA forms of the
enzyme is another indication for the presence of unique and
variable sequences on different forms of UDPGT since the
polyclonal antibody was made against a 3-MC induced protein.
Fig. 33. Antibody selection of inducer specific forms
of UOPGT.
Positive clones selected by immunoscreening
from the lambda gtll library were reacted
against polyclonal anti-3-MC UOPGT serum
to select monospecific anti UOPGT that recognize
only 3-MC and BHA + 3-MC induced forms of
UOPGT on a Western blot analysis of solubilized
microsomes.
Lanes 1 and 2.
Lanes 3 and 4.
Lanes 5 and 6.
Lane 7.
Lanes 8 and 9.











The biotransformation enzymes that seem to be dif¬
ferentially over-expressed in hostile chemical environments
are collectively involved in the normal chemical defense
arsenal of the cell. In this respect, UOPGT catalyzed glu-
curonidation of endogenous and exogenous chemicals has been
acknowledged as the major pathway in biotransformation due to
the ubiquitous nature and abundance of the co-substrate
(UDPGA) in the cell, UDPGT is a bonafide microsomal membrane
protein (Mackenzie, 1987) and, as such, the enzyme may have
structural functions that have not been investigated. More
than three forms of UDPGT isozymes have been demonstrated in
mammalian livers, which have been distinguished based on
induction, neonatal development, purification of specific
enzyme (Dragacci et al,, 1987) and substrate specificity
(Mackenzie, 1987; Stewart and McCrary, 1987), Attempts in the
past to chromatographically separate UDPGT from crude enzyme
preparations have not been entirely successful. In this
investigation, four isozymes of the enzyme were established
based on ion-exchange and UDPGA-agarose affinity chromato¬
graphies. The isoforms are identified here as peaks A,B,C
and D on the ion-exchange (Ananaba and Stewart, 1987), The
peak A eluted without salt (KCl) addition, while peaks B
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through D eluted with increasing salt concentration. Here,
the differences in these proteins based on their affinity for
the ion-exchange resin are apparent. In this regard, these
proteins have been grouped as cationic (peak A) and anionic
(peaks B through D). When these proteins were assayed for
p-nitrophenol U0P6T activity, the cationic form had little or
no measurable activity. However, on SDS/PAGE, two proteins of
52K and 54K were obtained from the cationic group. One of
these proteins may be a post-translational modification form
of the other, or two different proteins that co-eluted on
UDPGA-agarose affinity columns. Most of the activity was
detected in the anionic group. The absence of p-nitrophenol
UOPGT activity in the cationic group in our hands, does not
mean non-existence of other UOPGT forms in this region.
Tephly et al . (1984) showed estrone-UDPGT activity and
Falany et al. ( 1986) demonstrated beta-hydroxysteri od UOPGT
in this region also. The distribution of p-nitrophenol UOPGT
activity in this study may have been influenced by the purifi¬
cation conditions. Here, ammonium sulphate precipitation was
omitted to cut down on the quantity of enzyme lost, as well
as reduction in activity. Moreover, the purification buffer
was always at a pH of 7.4, which can change the charge distri¬
bution on this enzyme since p-nitrophenol UOPGT has a pi of
6.8. Therefore, the isozymes that have been identified here
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are different both in substrate specificity as well as charge
and amino acid residues that make up the polypeptides.
To further purify these proteins, the anionic peaks were
pooled and subjected to UOPGA-agarose affinity chromatography.
The column was first eluted with the purification buffer,
followed by 5 mM UDPGA elution. Two major peaks were obtained
from the affinity purification. The fractions obtained here
were assayed for p-nitrophenol IJDPGT activity; measurable
activity was only detected in the 5 mM UDPGA eluates. Any
residual activity detected in the flow through fraction was
interpreted as possible low affinity forms of the enzyme. The
four isozymes that were identified here are consistent with
the observations made earlier by Dr. McCrary (dissertation
research). The purification procedure employed here was
found to be very cost effective and less time consuming than
those previously published. The distribution of the proteins
was found not to be treatment dependent, rather xenobiotic
dependent, since the untreated rat liver samples consistently
did not have the peak B of the anionic group. We have puta¬
tively classified this peak as a xenobiotic specific form of
the enzyme. Other interesting differences observed between
the treated and untreated livers were the degree of liver
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enlargement and lipid accumulation. Hepatomegaly and hyper¬
lipidemia were not observed in the untreated samples. Among
the treated samples, these symptoms were more pronounced in
the BHA + 3-MC treatments, while there was no significant
differences between the BHA and 3-MC treatments. Also, the
treated animals showed appreciable change in body weight,
which was additive in the BHA + 3-MC treatments compared to
the BHA or 3-MC treatments. In comparison of the liver versus
body weight ratios of the treated and untreated animals,
a significant difference was observed {p<,05). While the dif¬
ference between the BHA and 3-MC treatments was not signifi¬
cant, the combined treatment result was more than additive.
Brown and Browne (1986) reported diffuse hyperplasia, hyper¬
trophy, and fatty acid degeneration of fish hepatocytes in
microscopically examined specimens. They reported enlarged
liver when fish were treated with radioactive ash. It has
been reported that pyrolysis of some organic materials (such
as ash) can generate compounds like polycyclic aromatic
hydrocarbons which can potentiate the expression of the genes
for the biotransformation enzymes including UOPGT, These
compounds may be responsible for the effects we as well as
Brown and Browne have observed in our different systems.
When the affinity purified samples were subjected to
SDS/PAGE analysis, we obtained two major proteins, Mp 80k and
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57k, Bock et al. ( 1979); Tukey et al. (1981); Falany et al ,
( 1983); Koster et al . (1986) have purified a 56k protein from
rat liver, which they separately showed to have p-nitrophenol
glucuronidation activity. By immunological and biochemical
assays, we were able to demonstrate that the 57k protein is
the active p-nitrophenol UDPGT. However, we were unable to
assign a function to the 80k protein that copurified with the
active protein in all the treatments. Nevertheless, this pro¬
tein showed cross-reactivity with antibody raised against the
57k protein. The specific origin of this protein cannot be
established until a function could be assigned to it. For
now, we consider it a purification artifact that is unique
to the system adopted here. However, UOPGT has been sug¬
gested to exist in precursor form which has a molecular
weight greater than 57k (lyanagi et al , 1986), It is then
possible to postulate that the 80k protein obtained here may
be the precursor UDPGT that is processed to the mature 57k.
The affinity purified cationic group of proteins showed a 52k
major band when analyzed on SDS/PAGE, with minor bands at
about 60k, which we consider contaminants or low affinity
forms of the enzyme from the anionic group. The 52k proteins
have no measurable p-nitrophenol UOPGT activity.
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In this work, total poly(A'‘') RNA, polysomes and UDP6T
specific polysomal poly(A''') RNA were isolated. The different¬
ial accumulation of these molecules in different treatments
confirmed the additive effect of the combined treatments that
was observed when protein and enzyme activity were analyzed.
Here, we demonstrated a stochiometric relationship between
the protein (UDPGT), enzyme activity and transcriptional acti¬
vity in treated animals. The polysome is a complex molecule
containing among other protein translation factors, mostly
ribosomes, mRNA, tRNA and nascent polypeptides. The over¬
accumulation of polysomes in treated tissues correlates with
the accumulation of its individual components. Since rRNA
and tRNA are transcribed, but not translated, we infer that
the over-expression of these molecules and the differential
expression of p-nitrophenol UDPGT observed in this investi¬
gation resulted from increased transcriptional events.
Jackson et al . ( 1986) and Mackenzie (1986) individually
demonstrated that over-expression of mRNA in phenobarbital
treated chicken embryo liver and rat liver mRNA, respective¬
ly, are transcriptionally mediated phenomena. Based on the
structural unrelatedness of the inducers (BHA and 3-MC), we
believe that they activate mRNA expression by different
mechanisms. However, they seem to induce the expression of
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p-nitrophenol UDPGT forms from different genes as indicated
by the biochemical and immunological studies (Ananaba et al ,,
1987). Iversen et al. (1987) recently demonstrated synergy
of phenobarbital and 3-methylcholanthrene in “superinduction"
of cytochrome P-450C mRNA, but no corresponding increase in
enzyme activity was observed. From these observations, it
appears that synergy is a characteristic of some multiply
induced systems. On the contrary, Stewart and McCrary (1987)
showed that BHA + 3-MC induction does not result in additive
expression of neither 1-naphthol nor phenolphathal ein UDPGT.
The differences in ability to exhibit synergy may be due to
different mechanisms employed by the cell to activate the
gene(s) that express these proteins.
To evaluate the immunological relationship among UDPGTs
from different treatments, we immunoabsorbed out the acti¬
vity from purified samples using rabbit anti-UDPGT made
against the 3-MC induced enzyme. The differential inhibition
obtained here was interpreted as an indication of different
populations of anti-UDPGT in the serum. There are populations
that recognize conserved sequences among UDPGT forms and
those that recognize unique epitopes on different UDPGTs.
This observation was substantiated by an antibody select study
in which the affinity purified monospecific antisera recognized
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only U0P6T from BHA + 3-MC and 3-MC in a Western blot ana¬
lysis. The affinity purification process selected against
BHA forms of p-nitrophenol UDPGT. Here, also, the intensity
of the band was more pronounced in the BHA + 3-MC microsomal
samples, which correlates with the synergistic expression of
the specific mRNA and enzyme activity shown by Stewart and
McCrary (1987). Furthermore, the cross-reactivity among
different forms of UDPGT against antibodies from a particular
treatment was determined by Ouchterlony double immunodiffusion
and immunoblot assays.
UDPGT has been localized on endoplasmic reticulum mem¬
brane as well as the nuclear envelope. The activity of
the enzyme on these membranes is stimulated by detergent
treatments which affect the organization of the membranes
{Mackenzie, 1987). We were able to show anti-UDPGT immune
reactivity against unsolubilized microsomes. This is evidence
that the enzyme is transmembrane and possibly located on the
luminal side of the ER (lyanagi et al., 1986). lyanagi et
al. (1986) have predicted the amino acid sequence of p-nitro-
phenol UDPGT from its cDNA, and showed that the hydrophobic
domain (487-510) proximal to the -COOH terminus was surrounded
on both sides by short segments of highly charged amino
acids, which is characteristic of a halt-transfer signal that
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functions to anchor the enzyme to the membrane, with -COOH
terminal charged amino acids on the cytoplasmic surface.
In addition to the immunological studies which show the
presence of conserved and variable epitopes among UDPGT
forms, our tryptic digest analysis showed some homologous
and unique amino acid sequences between p-nitrophenol UDPGT
from BHA and 3-MC treated animals. Moreover, when the rat p-
nitrophenol UDPGT was reacted against goat anti-mouse serum,
cross-reactivity was observed. Based on these results, we
infer that different species of UDPGT have a common origin,
however, the functions of the conserved and unique regions in
these enzymes have not been studied. Since UDP-glucuronic
acid is a common donor substrate for all UDPGT, we postulate
that at least some part of the conserved region corresponds
to the binding site for the nucleotide and glucuronic acid
moieties. Tntra- and inter-species similarities in UDPGT
forms have been well documented, however, little research
has been done on the differences. The observation made here
is consistent with the result of lyanagi et al, (1986), who
showed that nucleotides 35-371 are highly variable and nucleo¬
tides 372-1771 are highly conserved in p-nitrophenol and
androsterone UDPGT. It is then possible to conclude that
the differences in primary structure we have observed in
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trypsin digest analysis are due to amino acids coded by
the first four hundred nucleotides in the different UOPGT
genes. A comparison of the hydropathy analysis of the p-
nitrophenol UOPGT amino acid deduced by lyanagi et al . ( 1986),
and a phenobarbital inducible form of UOPGT deduced by
Mackenzie (1986), show no major differences. Furthermore,
Jackson et al . ( 1987) compared the hydrophobicity profiles of
human (HLUG 25) and rat (PLUG 38) UOPGTs and found identical
profiles. When they compared the cDNA sequences from these
two species, they found 73% homology throughout the coding
region, with two single-codon gaps in the human sequence
required to maximize homology; however, homology between the
5'- and 3'-terminal non-coding sequences was not apparent.
Recently, Harding et al . (1987) compared the amino acid
sequence obtained from translation of the cDNA with the
amino-terminal sequence of purified 17-beta-hydroxysteriod
UOPGT protein and showed identical 38 amino acid sequences
starting at residue 23 (end of cleaved signal sequence resi¬
dues). Restriction map analysis performed for rat p-nitro-
phenol UOPGT cDNA by lyanagi et al . (1986) and by Jackson et
al. (1987) for a human UOPGT showed almost identical profiles.
Jackson and his group showed that the human forms of UOPGT
used UAA as the stop codon while rat forms used UAG for
t ranslation
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Several possible mechanisms have been postulated to
explain the overexpression of biotransformation enzymes obser¬
ved in xenobiotic induced tissues, particularly the liver,
which is the most studied (Maniatis et al., 1987). Among
these are the effects of cis-acting upstream and/or down¬
stream sequences; sequences that influence gene expression
irrespective of their orientation to the coding sequence
(enhancers), the absence or presence of trans-acting factors
in the cytosol that are activated by the inducers, and
the possible existence of a separate gene for each enzyme
form that is regulated by its own specific inducer(s). These
genes are expressed synergistical 1y or additively in combined
xenobiotic stimulation.
Since we do not understand the exact regulatory mechan¬
isms that control UOPGT expression, we can only speculate
based on the studies that have been done on some closely
related enzymes such as P-450 as well as other eukaryotic
proteins. P-450 has been shown to belong to the same [Ah]
battery of genes as UDPGT, and they are concomitantly express¬
ed (Nebert and Gonzalez, 1987). Sogawa et al. (1986) showed
that there are regulatory sequences on the P-450c promoter
that are capable of conferring inducibility on a heterologous
promoter independent of its orientation and distance from the
subordinate promoter. These sequences were referred to as
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"drug regulatory elements" (ORE), and they respond to 3-MC
which is a prototype inducer for both P-450 and UDPGT. Work
done by Hammer et al. (1987) on the diversity of alpha-feto¬
protein gene expression showed that tissue specific trans¬
acting factors act on separate enhancers to bring about over¬
expression of the gene. Similar diversity has been observed
in UDPGT gene expression, therefore, we cannot rule out the
possibility of separate enhancers as a contributing factor to
this phenomena. In addition, the role of trans-acting factors
in eukaryotic gene expression has not been well studied,
however, it has been demonstrated that co-operative binding
of factors and accessibility of the binding sites may be
required for the mechanism of gene activation (Sas sone-Co rs i
and Borrelli, 1986). Moreover, the additive effects of
tandemly reiterated regulatory elements on eukaryotic gene
expression appear to be a general phenomenon (Maniatis et
al., 1987). This has been demonstrated in heat-shock (Dudler
and Travers, 1984) and beta-interferon genes (Goodbourn et
al. , 1985). There is also some evidence that the number of
reiterated elements for efficient induction can vary among
different cell types (Goodburn et al . , 1985), which presum¬
ably reflects differences in the levels or kinds of trans¬
acting factors in these cells. One can then postulate that
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both the differential expression and overexpression of UDP6T
forms are controlled by reiterated regulatory elements. An
alternative explanation of the differential expression of
UDPGT genes involves tissue-specific enhancers which may
contain different elements for binding constitutive and tissue
specific factors, with binding of both types of factors
required for full activation of the reiterated enhancers.
It has been shown that some DNA segments act as enhancers
only under specific conditions which are generated by the
presence of an inducer. Inducers like BHA and 3-MC can act
either directly or via a cellular mechanism for receiving and
transducing the external signal, to effect the transcription
of a specific gene or genes. Therefore, the inducers can be
considered as types of trans-acting co-factors. Because of
the limited knowledge presently available on eukaryotic gene
expression, we cannot over-generalize the role of inducers,
enhancers and trans-acting factors on gene expression.
We have demonstrated considerable amino acid differences
between BHA and 3-MC forms of p-nitrophenol UDPGT, which
implies the existence of more than one gene for this enzyme.
We are cognizant of other factors that can result in over¬
expression of a single gene. For instance, the additive
effect obtained here in the combined inductions, may be a
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consequence of enhancer-1ike elements regulated by tissue-
specific trans-acting factors activated by the inducers. The
role of these putative sequences in modulating chemically
induced gene expression has not be well investigated to
contradict the existence of separate p-nitropheno1 UDPGT
genes induced by BHA and 3-MC. In addition, undermethylation
has been documented as a possible mechanism in eukaryotic
gene expression (Ploeg Vander et al., 1980). Actively
transcribed genes are hypomethylated. Irrespective of the
evidences in favor of methylation in gene expression, it is
premature to speculate on the possibility of hypomethylation
as a mechanism for the differential expression we have obser¬
ved among the different treatments utilized in this study.
It should be apparent from this investigation that much
of the molecular basis of chemical mediated over-expression
of biotransformation enzymes is yet unsettled. However,
the data obtained here have increased our knowledge of the
relationships that exist among different forms of UDPGT, and
advanced our understanding of the molecular basis of eukary¬
otic gene expression as well the evolution of these proteins.
CHAPTER VI
SUMMARY AND CONCLUSIONS
One of the many fundamental difficulties in eukaryotic
molecular biology is to understand the mechanisms by which
individual genes are expressed in response to exogenous and
endogenous inducers. In this study, we have attempted to
contribute to the general understanding of eukaryotic cell
and molecular biology by elucidating some of the inter¬
relationships that exist when 3-MC and/or BHA are used to
activate UDPGT genes. The experimental results obtained in
this investigation allow us to make several statements
regarding the expression of rat liver p-nitrophenol UDPGT.
1. Although significant increase in macromolecule (e.g.,
proteins, lipids and nucleic acids) accumulation was
observed in all the treatments compared to the untreat¬
ed, hepatomegaly and hyperlipidemia were more prevalent
in BHA + 3-MC treated animals compared to either BHA or
3-MC used alone.
2. Elimination of ammonium sulfate precipitation in the
purification process and differences in amino acid
residues among UDPGT isoforms resulted in an anionic




3. Despite a bias towards 3-MC 57k protein, polyclonal
antibody against 3-MC p-nitrophenol UDPGT crossreacts
with UDPGT from the other treatments and a 3-MC 80k
protein that co-purified with the 57k protein.
4. Goat anti-mouse UDPGT also cross-reacts with the 57k
protein (p-nitrophenol UDPGT) from all the treatments,
which demonstrates the inter and intra species conser¬
vation of amino acid sequences among these polypeptides.
5. Antibody against the 57k protein recognizes epitopes
on unsolubilized microsomes, which indicates that this
protein tranverses the microsomal membrane.
6. Differential inhibition of p-nitrophenol UDPGT activity
by the polyclonal antibody indicates the uniqueness of
the enzymes from different treatments. Moreover, the
tryptic digest analysis as well as the antibody select
studies validate the assumption that BHA and 3-MC
activate the expression of p-nitrophenol UDPGT that are
functionally similar, but structurally different.
7. The presence of numerous positive clones in the lambda
gtll cDNA library may reflect the multiplicity of UDPGT
genes in rat liver and possible amplification of the
positive clones.
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8. Based on the information obtained here, we maintain
that simultaneous exposure to multiple inducers
results in over expression of some rat liver UDPGT
genes, and conclude that the synergism we have observed
may be due to the induction of separate UDPGT genes
by BHA and 3-MC.
In this study, as in any other scientific investi¬
gation, we have answered some questions, and created new
questions that require further study. Our lab is cur¬
rently attempting to improve on the separation of the
p-nitrophenol UDPGT isoforms, and at the same time scale
up its yield for future in depth analysis. In addition,
we are characterizing UDPGT cDNA inserts to establish
specific nucleotide differences between BHA and 3-MC forms
of the enzyme. To test some of the theoretical models pre¬
sently available on the mechanism of genetic regulation,
and the determination of UDPGT structure and forms, it
will be essential to design and build chimeric molecules
that have UDPGT coding sequences and known regulatory
element s.
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